data_2krn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2krn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 121.321 0.581 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.9 p -110.01 131.28 55.2 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.118 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -91.68 148.25 22.4 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.405 ' HA ' HG12 ' A' ' 56' ' ' VAL . 43.1 t -88.22 114.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.02 -34.26 9.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 123.802 0.689 . . . . 0.0 111.513 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -121.79 160.68 24.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.271 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.71 131.18 35.26 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.601 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -131.46 113.01 13.19 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.214 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.6 m -94.1 106.75 24.18 Favored Pre-proline 0 N--CA 1.403 -2.783 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 37.1 Cg_endo -64.01 149.89 89.54 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.309 2.673 . . . . 0.0 113.836 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -88.45 -30.04 19.73 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.357 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 38.0 m-80 -130.0 156.61 44.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.88 -7.39 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.942 0.877 . . . . 0.0 110.63 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.74 -21.72 60.12 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 63.3 mt-10 -84.24 126.02 32.76 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.26 132.1 44.44 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.397 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.25 114.32 7.39 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 122.164 0.983 . . . . 0.0 111.791 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 mt -87.0 104.79 16.64 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.322 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.67 120.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.613 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.93 121.04 12.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 -28.61 7.93 Favored Glycine 0 N--CA 1.427 -1.922 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.332 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.3 175.59 8.82 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.765 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -124.14 137.72 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.6 mt -109.28 130.71 61.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 121.136 0.493 . . . . 0.0 109.957 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.1 107.25 17.75 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.8 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.117 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.39 -59.64 2.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -164.22 157.67 18.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.5 139.59 30.54 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -106.48 -44.21 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.5 70.01 1.38 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.574 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 52.33 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.959 1.704 . . . . 0.0 113.585 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -71.5 -42.84 54.85 Favored Glycine 0 N--CA 1.419 -2.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.362 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -89.31 111.93 22.88 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.81 0.814 . . . . 0.0 111.949 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -101.2 164.27 11.87 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.788 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 m -124.78 120.62 32.28 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.946 0.403 . . . . 0.0 110.288 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.79 178.33 36.82 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -129.15 138.68 51.92 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.336 0.589 . . . . 0.0 110.827 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -111.01 101.03 9.62 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 68.39 -78.93 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.483 1.113 . . . . 0.0 113.068 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -131.14 -6.79 3.87 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -107.02 125.54 51.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.218 0.533 . . . . 0.0 110.923 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.18 136.53 37.56 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.28 -179.05 39.96 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 118.903 -1.618 . . . . 0.0 113.28 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 72.6 mt -99.17 137.71 37.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.63 141.54 22.96 Favored Pre-proline 0 C--N 1.291 -1.974 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.166 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 61.1 Cg_endo -78.71 128.88 8.86 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.378 2.052 . . . . 0.0 112.552 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 p -72.81 21.6 0.07 Allowed 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.152 1.381 . . . . 0.0 113.271 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 52' ' ' PRO . 26.6 t-20 -90.54 -42.71 10.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -90.27 -12.04 39.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.702 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 9' ' ' VAL . 32.6 m -121.6 140.07 46.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.976 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -121.39 141.71 50.71 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.744 0.307 . . . . 0.0 110.92 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--N 1.308 -1.222 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.775 0 CA-C-O 121.333 0.587 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 25.7 p -111.48 152.39 27.5 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.971 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -100.49 144.9 28.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.69 109.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.56 -38.91 11.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 90.4 m-85 -127.75 156.24 42.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -99.34 162.44 13.04 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.843 -175.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HA ' ' A' ' 15' ' ' PRO . 41.3 t80 -137.38 124.05 21.06 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -91.53 105.6 13.64 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 141.2 94.18 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.198 2.599 . . . . 0.0 112.671 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.2 -36.79 69.28 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.01 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 16.2 m-80 -129.39 161.87 29.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.97 4.36 19.81 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.68 -19.43 45.2 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.4 mp0 -86.03 139.26 31.32 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.037 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -75.16 129.67 37.92 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.0 109.01 2.81 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 122.22 1.009 . . . . 0.0 110.56 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 43.3 mt -84.34 112.96 20.8 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 113.726 -1.579 . . . . 0.0 108.494 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -111.64 126.55 69.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 12' ' ' ASP . 43.4 t -61.09 128.33 22.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 O-C-N 123.428 0.455 . . . . 0.0 111.183 -176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.71 -39.25 2.8 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.259 -0.972 . . . . 0.0 114.128 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -86.36 176.31 7.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.895 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.3 141.04 30.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 124.131 0.972 . . . . 0.0 109.319 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 74.8 mt -112.92 131.63 63.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.76 106.78 17.25 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -93.56 140.5 16.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.381 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -80.52 -64.8 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -173.56 170.16 4.16 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.38 127.98 32.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.07 -31.65 3.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.914 0.388 . . . . 0.0 111.38 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 43.8 mt-10 -137.89 168.31 19.95 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.77 91.89 1.97 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.373 0.606 . . . . 0.0 110.545 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 116.73 -11.76 15.55 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.938 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 90.6 m95 -117.89 116.95 27.98 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.352 0.596 . . . . 0.0 110.402 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -105.58 155.33 19.31 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 t -118.79 139.73 51.1 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.07 -172.26 44.79 Favored Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.7 t -130.53 146.1 51.99 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.79 -62.28 1.59 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -176.11 22.81 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.514 1.526 . . . . 0.0 107.295 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -172.11 -67.73 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.317 -169.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.87 120.03 25.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.83 133.25 53.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.48 -153.19 8.32 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.969 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.5 mm? -111.43 144.8 40.05 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -150.41 145.21 18.25 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-N 118.23 0.468 . . . . 0.0 111.3 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 54.7 Cg_endo -73.9 130.47 14.52 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.05 1.833 . . . . 0.0 110.766 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -78.99 17.34 0.76 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -75.05 -46.72 32.97 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.748 0.785 . . . . 0.0 109.173 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 54.8 m-85 -87.33 -6.95 58.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.084 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.02 142.32 38.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.853 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -122.27 128.82 51.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 123.526 0.73 . . . . 0.0 109.927 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 . . . . . 0 CA--C 1.506 -0.744 0 CA-C-O 120.582 0.229 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HG ' ' HB ' ' A' ' 29' ' ' ILE . 22.7 p -144.27 135.26 25.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.391 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.43 148.33 24.86 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 O-C-N 124.156 0.91 . . . . 0.0 110.976 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.43 -47.77 6.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.25 146.46 45.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.434 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.44 138.97 39.56 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.154 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 19.2 t80 -113.48 -59.44 2.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.257 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t 64.0 100.69 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -170.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 44.5 Cg_endo -61.51 158.95 33.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.594 2.196 . . . . 0.0 112.781 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -92.91 -39.87 10.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -115.06 -173.58 2.34 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.828 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -85.18 -13.49 49.89 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.51 -43.18 63.93 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.582 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.9 mp0 -72.34 147.8 45.95 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.951 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.12 147.72 28.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -71.76 109.57 5.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.937 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 43.6 mt -102.67 110.76 22.8 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.038 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.93 134.42 62.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.81 127.14 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.609 0.719 . . . . 0.0 112.116 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.26 -4.32 70.33 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.257 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -95.99 169.77 9.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 117.882 0.841 . . . . 0.0 109.567 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.32 139.43 51.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.508 0.67 . . . . 0.0 111.121 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 ' HB ' ' HG ' ' A' ' 7' ' ' CYS . 61.3 mt -115.4 138.22 46.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.127 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -94.3 93.18 7.58 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.85 115.15 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.71 0.767 . . . . 0.0 110.467 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -71.24 -57.97 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.796 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -178.37 7.22 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.577 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -129.29 117.78 21.22 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.153 0.502 . . . . 0.0 111.386 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.2 -24.02 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.94 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -133.68 170.01 16.19 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.497 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.27 -45.9 24.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -84.58 -28.01 33.86 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.499 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.406 ' CZ3' ' HD3' ' A' ' 52' ' ' PRO . 91.7 m95 -115.24 117.28 30.06 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.494 0.664 . . . . 0.0 111.618 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -105.69 150.73 25.21 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 104.02 13.23 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.885 0.85 . . . . 0.0 110.797 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 167.42 24.37 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.962 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 t -114.09 131.49 56.38 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.08 -63.66 1.22 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.05 -72.12 0.7 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -123.64 -14.43 7.29 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.417 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -84.21 115.8 22.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.98 124.22 32.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.11 166.3 26.73 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 tp -97.72 138.18 35.48 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.29 149.9 33.19 Favored Pre-proline 0 C--N 1.295 -1.766 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.82 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 53.6 Cg_endo -71.34 122.01 8.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.715 2.277 . . . . 0.0 111.861 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 p -69.46 -10.64 58.9 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.774 0.83 . . . . 0.0 113.193 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.16 -15.48 60.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.737 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -101.99 7.01 41.47 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.363 -0.836 . . . . 0.0 112.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.67 167.22 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.88 145.97 48.77 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 . . . . . 0 C--N 1.295 -1.791 0 CA-C-O 121.238 0.542 . . . . 0.0 112.062 -175.431 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 . . . . . 0 C--O 1.241 0.623 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.7 p -83.24 131.44 35.1 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.031 -172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 57' ' ' LYS . 49.6 mttm -87.05 144.22 26.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.65 141.91 15.03 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.504 ' CD2' ' HD2' ' A' ' 57' ' ' LYS . 34.0 mt -99.94 -54.78 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 111.099 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -127.92 164.53 22.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.003 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.29 149.92 35.33 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.536 0.523 . . . . 0.0 110.856 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -146.75 113.43 6.03 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.5 t -103.84 108.0 58.4 Favored Pre-proline 0 N--CA 1.399 -3.021 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 29.2 Cg_endo -62.11 163.53 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.293 2.662 . . . . 0.0 112.732 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -92.87 -43.69 8.85 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -107.87 -173.14 2.21 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.14 15.64 25.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.24 0.543 . . . . 0.0 109.545 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.77 -36.77 13.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.371 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.3 mp0 -80.86 171.15 15.37 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 46.0 tp -106.24 139.81 40.17 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.4 164.17 26.79 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.573 0.701 . . . . 0.0 111.371 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.9 mt -133.27 124.39 27.24 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.28 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.44 123.78 68.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.09 116.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.453 0.644 . . . . 0.0 111.039 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.87 -8.96 29.71 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.398 -0.905 . . . . 0.0 112.966 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.33 177.88 5.81 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.15 134.38 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.515 0.726 . . . . 0.0 109.061 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -113.08 134.39 55.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.5 94.55 4.97 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.93 104.24 7.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.843 0.83 . . . . 0.0 109.136 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.2 mt -81.49 -58.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.186 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -138.55 169.27 18.1 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.457 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -115.96 137.51 52.05 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.68 -26.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.288 0.566 . . . . 0.0 110.489 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -138.07 178.15 7.34 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.91 -17.22 38.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.01 -1.36 20.82 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.523 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -136.13 124.63 23.54 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.018 0.437 . . . . 0.0 110.879 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.462 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 52.5 m0 -113.86 158.24 21.31 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.224 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -103.99 111.22 23.68 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.19 165.07 28.98 Favored Glycine 0 N--CA 1.424 -2.161 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.756 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 4.9 t -110.17 129.44 55.71 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -90.85 -74.74 0.49 Allowed 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.9 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.52 -21.68 12.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.245 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -165.9 -42.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.078 0.466 . . . . 0.0 110.441 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.8 mptm? -94.47 140.55 29.68 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.9 tp -90.43 101.36 14.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.801 -1.545 . . . . 0.0 106.948 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.17 177.29 18.59 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.794 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.6 mp -92.24 128.0 37.93 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.7 p90 -126.47 145.88 54.57 Favored Pre-proline 0 C--N 1.288 -2.082 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.687 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.48 113.11 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.614 2.209 . . . . 0.0 111.728 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.94 -24.44 62.53 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.875 1.27 . . . . 0.0 113.265 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.89 -22.33 64.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -99.39 16.19 23.91 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.818 -0.551 . . . . 0.0 111.959 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.49 162.15 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -119.42 126.2 50.78 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.161 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.88 178.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.243 0.725 0 CA-C-O 121.891 0.853 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.0 p -121.63 140.48 52.21 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.861 -172.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -93.61 154.39 17.87 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' A' ' 56' ' ' VAL . 48.6 t -82.12 129.87 36.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.527 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -96.14 -49.07 5.39 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.499 . . . . 0.0 109.848 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -130.8 147.88 52.51 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.63 135.41 45.49 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.499 0.5 . . . . 0.0 110.554 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.416 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 40.4 t80 -114.92 109.46 18.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -91.18 105.7 13.47 Favored Pre-proline 0 N--CA 1.403 -2.821 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 34.3 Cg_endo -68.47 163.2 37.58 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.055 2.503 . . . . 0.0 114.021 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.96 -33.1 39.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.205 1.002 . . . . 0.0 109.004 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -125.34 -168.5 1.84 Allowed 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -104.75 18.37 22.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.53 -47.01 13.65 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.149 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.7 mp0 -68.09 159.14 31.51 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 tp -80.87 125.72 30.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.58 122.77 20.36 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 122.015 0.912 . . . . 0.0 112.016 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.26 108.74 21.27 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.866 -1.515 . . . . 0.0 109.018 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 125.9 66.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.87 136.29 26.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.27 0.557 . . . . 0.0 110.558 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.02 -22.95 15.03 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.661 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.85 172.5 7.4 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.457 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.4 129.14 64.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 124.509 1.123 . . . . 0.0 108.802 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.51 132.65 60.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.11 105.67 17.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 12.8 p -86.71 148.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.209 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.1 -55.43 6.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.83 -176.32 1.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.18 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 11.9 pt-20 -107.39 141.66 38.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -96.46 -25.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.058 0.456 . . . . 0.0 110.779 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.33 151.98 38.38 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.86 94.23 0.82 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.648 0.737 . . . . 0.0 109.246 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 137.01 -23.13 3.22 Favored Glycine 0 N--CA 1.415 -2.713 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.905 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -124.75 114.8 19.76 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.609 0.719 . . . . 0.0 112.093 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 21.7 m0 -99.28 142.96 30.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.231 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -105.24 106.56 17.12 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 31' ' ' VAL . . . -145.98 167.73 27.72 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.28 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -111.79 131.23 55.47 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.656 0.741 . . . . 0.0 110.644 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.75 -34.51 69.55 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.246 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -164.27 -68.61 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.749 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.14 -16.23 6.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.03 110.23 20.46 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -89.55 131.22 35.68 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.6 174.92 35.73 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.339 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.14 136.36 37.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -142.64 145.14 32.97 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 56.2 Cg_endo -72.14 129.8 15.62 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 122.06 1.84 . . . . 0.0 112.17 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 5.6 p -79.24 15.34 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.495 ' OD1' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p-10 -95.1 -15.34 23.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.04 0.447 . . . . 0.0 109.887 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.22 6.74 28.92 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.051 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 9' ' ' VAL . 27.1 m -142.69 144.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -100.75 -107.64 0.22 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.294 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--N 1.296 -1.751 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 177.651 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 9.5 p -148.01 137.34 22.22 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.952 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HB2' ' HD3' ' A' ' 57' ' ' LYS . 3.5 mptp? -83.14 149.27 26.97 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.08 121.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.995 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.77 -47.04 7.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.0 110.897 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.82 146.53 45.62 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.54 162.22 22.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.067 0.461 . . . . 0.0 110.906 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -146.03 127.11 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.262 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 t -104.78 106.32 54.46 Favored Pre-proline 0 N--CA 1.416 -2.145 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.86 171.72 12.98 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 123.433 2.755 . . . . 0.0 114.445 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -86.71 -48.23 8.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.3 -177.83 3.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.969 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -85.86 -6.28 59.11 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.695 0.283 . . . . 0.0 110.393 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.14 -32.84 71.02 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.22 173.06 12.31 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.27 130.33 55.97 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.42 156.95 38.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 112.41 18.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.89 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mm -94.31 122.16 45.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.65 126.01 20.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.383 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 -15.44 63.34 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.054 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.26 -172.46 3.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.173 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.59 136.4 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 121.633 0.73 . . . . 0.0 111.672 -174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 75.0 mt -110.28 134.6 51.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.876 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.56 120.47 43.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.0 mt -88.14 -49.21 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -170.69 147.14 2.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.07 106.71 18.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.19 -40.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.038 -174.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -122.52 168.05 12.62 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.89 110.96 9.62 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 106.24 -26.7 19.53 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.264 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.56 114.48 28.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.413 0.625 . . . . 0.0 110.986 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -99.09 145.57 27.0 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.965 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -105.32 113.75 27.52 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.1 -177.62 27.7 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.296 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -133.14 129.37 37.79 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.5 tp -84.31 -65.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -104.05 -72.82 0.69 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -137.13 -5.44 1.87 Allowed 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.576 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -99.77 121.42 41.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.62 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 tt -77.64 128.17 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 169.5 32.85 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.81 132.76 36.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -139.87 144.92 40.47 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 58.1 Cg_endo -74.87 125.99 9.76 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.071 1.847 . . . . 0.0 111.851 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 p -60.45 -22.61 63.65 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.465 1.106 . . . . 0.0 112.499 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -58.27 -27.1 63.71 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.928 0.891 . . . . 0.0 112.4 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.63 -2.93 40.45 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.851 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 158.02 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 8' ' ' LYS . 19.0 ptmt -101.86 -11.6 18.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.143 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 CA--C 1.561 1.37 0 O-C-N 124.117 0.886 . . . . 0.0 108.779 -175.741 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 . . . . . 0 CA--C 1.509 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 26.7 p -114.92 152.54 32.12 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.828 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -107.6 149.8 27.62 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.764 0.316 . . . . 0.0 110.338 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.4 113.38 26.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.225 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 57' ' ' LYS . 57.7 mt -107.0 -38.92 5.9 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.887 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -107.57 159.47 16.42 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.77 148.6 24.23 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' HD11 ' A' ' 23' ' ' LEU . 9.5 t80 -114.57 -67.96 0.96 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.8 t 67.44 101.95 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -169.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.11 161.61 36.44 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.757 2.305 . . . . 0.0 113.321 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -87.29 -38.19 16.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.564 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 21.1 m120 -119.18 -175.45 2.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.865 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.82 -3.28 49.25 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.435 0.636 . . . . 0.0 109.577 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.56 -52.93 21.71 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.902 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.564 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -60.6 164.05 4.9 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.836 0.826 . . . . 0.0 111.615 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.4 tp -90.7 132.26 35.9 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.6 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.77 158.32 36.52 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-O 121.586 0.707 . . . . 0.0 110.078 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 13' ' ' TYR . 46.6 mt -123.98 101.21 7.12 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.229 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.11 120.43 38.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.1 t -63.67 124.66 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.864 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.03 -12.21 55.89 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.913 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.99 155.06 19.72 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.088 0.47 . . . . 0.0 111.889 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.31 135.78 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.53 119.55 60.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.53 117.16 22.33 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.96 143.9 15.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -88.8 -57.26 4.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.76 164.2 21.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -92.11 120.65 32.92 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.02 -29.23 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.635 0.731 . . . . 0.0 109.085 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 21.9 mm-40 -130.81 157.82 41.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -77.23 -26.85 53.05 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.727 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -90.06 -37.6 6.7 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.694 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -110.02 109.82 20.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.21 0.529 . . . . 0.0 110.772 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.587 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.0 m0 -94.35 163.98 13.2 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.225 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -115.37 114.29 24.91 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.088 0.471 . . . . 0.0 110.637 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.94 177.47 34.66 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -125.12 144.09 50.6 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.936 0.368 . . . . 0.0 110.108 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.38 -68.24 0.8 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -122.7 -49.5 2.0 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.05 -37.13 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.758 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.82 118.51 28.57 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.675 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -91.92 119.17 31.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.07 14.64 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.33 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.4 mp -100.24 146.18 27.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.764 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.09 147.03 22.52 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.545 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 51.4 Cg_endo -75.01 129.3 12.21 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.988 1.792 . . . . 0.0 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 p -75.52 21.09 0.15 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.404 1.082 . . . . 0.0 112.958 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -87.65 -44.06 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.388 0.613 . . . . 0.0 110.008 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.3 -7.53 56.6 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.265 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.21 146.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.317 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HD3' HD11 ' A' ' 10' ' ' LEU . 4.0 mptp? -127.38 144.93 50.98 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 173.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 30.0 tt0 . . . . . 0 N--CA 1.416 -2.135 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.37 128.83 54.44 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -83.94 147.31 27.55 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.668 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.5 t -90.56 133.72 31.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.408 HD12 ' HD3' ' A' ' 57' ' ' LYS . 62.1 mt -95.1 -58.6 2.1 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.758 0.823 . . . . 0.0 109.526 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.12 160.18 24.24 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.088 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.4 158.58 24.58 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.166 0.508 . . . . 0.0 110.156 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.3 -58.3 2.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t 71.4 105.4 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.537 1.135 . . . . 0.0 109.105 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.23 154.86 43.45 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.279 1.986 . . . . 0.0 111.448 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -83.74 -29.46 27.45 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.463 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 13.2 m120 -112.13 -80.37 0.59 Allowed 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.504 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 167.6 -24.96 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.296 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.68 -21.72 61.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -74.7 150.98 39.28 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.12 117.65 20.35 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.973 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.18 126.75 28.72 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.342 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 51' ' ' PHE . 38.7 mt -91.9 117.02 29.4 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.47 114.11 28.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.228 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.76 127.08 26.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.348 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.97 -9.86 75.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.458 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.66 178.99 4.4 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.32 129.39 73.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.775 0.321 . . . . 0.0 110.926 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.86 141.08 15.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 123.535 0.734 . . . . 0.0 110.696 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.72 95.72 9.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.93 144.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.579 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.8 mt -113.74 -54.78 4.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.91 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -155.65 160.99 40.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 8.6 pt-20 -100.91 142.92 31.7 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 m -100.35 -25.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 44.7 mt-10 -139.11 164.82 28.78 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.03 -39.14 91.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 123.548 0.53 . . . . 0.0 110.16 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.83 -40.19 5.98 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.039 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -92.14 105.87 18.01 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.768 0.794 . . . . 0.0 111.638 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 43.6 m0 -93.74 153.49 18.3 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.014 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -109.7 120.5 42.69 Favored 'General case' 0 C--O 1.261 1.705 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.2 177.93 36.45 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -134.55 166.46 22.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.56 -60.53 0.79 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.36 0.6 . . . . 0.0 109.617 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -114.27 -69.74 0.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -128.22 -29.31 2.51 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.993 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -85.82 121.81 28.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.074 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 tp -98.93 107.01 19.33 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.75 -169.53 18.11 Favored Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 112.653 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 71.7 mt -96.93 146.22 25.16 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.837 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' HD22 ' A' ' 23' ' ' LEU . 44.1 p90 -147.42 147.5 28.38 Favored Pre-proline 0 C--N 1.299 -1.614 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.736 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.81 123.23 7.83 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.362 2.041 . . . . 0.0 111.701 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 56' ' ' VAL . 32.9 t -71.51 -10.96 60.57 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.24 -21.66 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.639 -0.663 . . . . 0.0 112.35 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.69 10.39 41.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.813 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 21.7 m -133.4 155.87 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.723 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 4.3 mptp? -122.45 126.43 47.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.554 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--N 1.312 -1.04 0 C-N-CA 124.416 1.086 . . . . 0.0 111.89 -175.127 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.89 149.04 24.61 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.328 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -98.64 143.01 29.49 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.397 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 56' ' ' VAL . 21.6 t -84.97 108.03 16.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.957 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.36 -34.6 17.55 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.861 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.27 150.28 50.99 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.467 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -80.49 158.43 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.142 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -150.16 110.06 4.1 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.751 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -97.95 107.55 41.22 Favored Pre-proline 0 N--CA 1.411 -2.377 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.33 154.67 2.44 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 124.543 3.495 . . . . 0.0 114.457 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.13 -21.86 25.71 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.252 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -130.95 -161.72 1.15 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -105.18 7.05 33.52 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.527 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.49 -43.26 40.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.824 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.16 159.16 30.96 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.574 0.702 . . . . 0.0 111.041 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.61 143.78 28.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.91 120.57 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.1 mt -97.72 120.47 38.16 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.138 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.83 122.59 69.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.24 130.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 123.98 0.912 . . . . 0.0 112.827 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.25 -3.62 64.19 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.528 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.2 -178.48 3.67 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.18 138.74 53.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.694 0.798 . . . . 0.0 108.984 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.54 134.11 52.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.626 0.251 . . . . 0.0 110.452 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.65 96.7 4.9 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.51 129.54 36.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.256 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.7 mt -98.59 -61.35 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.5 176.81 6.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.7 pt-20 -108.32 128.3 54.62 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.983 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.97 -35.54 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.58 170.0 16.72 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.255 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.42 93.95 3.02 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.38 -35.79 3.1 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -99.84 114.18 27.19 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.334 0.588 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.9 m0 -99.66 158.37 15.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -111.99 120.38 41.69 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.23 33.85 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.536 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.9 m -105.92 128.37 53.74 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -81.25 -60.17 2.38 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -140.22 -65.72 0.45 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.033 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.83 -17.21 12.1 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.513 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -120.67 142.45 49.46 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.262 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 49' ' ' GLY . 5.7 tt -94.35 135.75 35.42 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' N ' HD22 ' A' ' 48' ' ' LEU . . . -150.45 170.2 30.36 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.068 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 69.5 mt -101.39 131.08 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -139.81 146.14 45.9 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.236 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.74 133.24 8.01 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.142 1.895 . . . . 0.0 111.366 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -80.44 42.58 0.6 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.781 0.801 . . . . 0.0 111.348 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -102.22 -40.56 6.72 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.22 -9.42 45.35 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 9' ' ' VAL . 35.9 m -127.01 140.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.734 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -124.6 142.08 51.62 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.628 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.378 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 51.2 mt-30 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-O 120.862 0.363 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.7 p -120.74 155.94 32.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.258 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.6 mttm -105.72 140.13 39.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.572 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.79 118.79 26.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.139 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -101.82 -34.38 9.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.809 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -124.52 154.39 40.63 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.81 154.02 28.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -113.58 -52.46 2.75 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.624 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m 58.67 88.35 0.12 Allowed Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 110.487 -173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.19 153.46 39.39 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.05 2.5 . . . . 0.0 113.173 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.62 -17.68 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.73 -167.08 1.92 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.29 5.91 32.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.66 -31.18 16.72 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.225 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 2.8 mp0 -74.85 178.67 5.36 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.382 0.61 . . . . 0.0 110.134 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.7 tp -94.73 136.25 35.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -84.49 117.06 23.44 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.976 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 mt -89.96 108.42 19.71 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.696 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.22 127.62 41.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.7 p -68.54 128.14 31.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 CA-C-O 121.803 0.811 . . . . 0.0 112.253 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.67 87.59 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.882 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 3.7 t0 -87.25 169.24 12.49 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.476 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.7 t -114.27 129.36 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.322 0.649 . . . . 0.0 110.709 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.31 134.83 53.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 122.972 0.509 . . . . 0.0 110.863 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 33.5 t70 -86.69 105.19 16.76 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 t -84.85 121.29 36.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.101 -176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -90.09 -50.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.76 152.86 18.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.158 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.9 pt-20 -90.1 124.43 34.8 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 168.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.49 -34.99 7.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.818 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -138.29 153.51 49.04 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -71.54 112.61 7.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.225 0.536 . . . . 0.0 109.856 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 110.32 -13.02 30.95 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.423 -177.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -126.7 107.02 9.79 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.38 0.609 . . . . 0.0 110.876 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.3 m0 -94.54 143.53 26.34 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -107.56 114.8 29.04 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.03 170.79 34.37 Favored Glycine 0 N--CA 1.42 -2.404 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -118.5 141.82 48.19 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.84 -54.92 4.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -132.54 -59.99 0.9 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.117 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.06 -21.6 2.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -101.91 115.64 30.98 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.955 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.97 108.54 5.94 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.83 173.2 16.56 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.954 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 18.1 tp -107.35 139.75 41.34 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -150.64 147.58 21.61 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 121.365 -0.134 . . . . 0.0 110.984 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 41.0 Cg_endo -71.3 129.45 15.99 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.089 1.859 . . . . 0.0 111.3 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -68.02 -22.29 64.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.7 0.8 . . . . 0.0 112.844 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -57.32 -33.06 67.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.964 0.506 . . . . 0.0 112.36 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -90.48 -6.66 54.57 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.402 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 27.3 m -118.48 137.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.229 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 13.5 mptt -116.19 131.87 56.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.802 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--N 1.293 -1.874 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.995 -174.456 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.445 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -100.66 -6.24 25.45 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.416 -0.461 . . . . 0.0 111.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.6 mmt 60.87 38.82 17.56 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.96 141.39 45.22 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.234 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -102.54 159.29 15.57 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.312 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -68.72 141.33 55.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.905 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.9 p -110.01 131.28 55.2 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.118 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -91.68 148.25 22.4 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' HA ' HG12 ' A' ' 56' ' ' VAL . 43.1 t -88.22 114.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.02 -34.26 9.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 123.802 0.689 . . . . 0.0 111.513 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -121.79 160.68 24.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.271 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.71 131.18 35.26 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.601 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -131.46 113.01 13.19 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.214 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.6 m -94.1 106.75 24.18 Favored Pre-proline 0 N--CA 1.403 -2.783 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 37.1 Cg_endo -64.01 149.89 89.54 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.309 2.673 . . . . 0.0 113.836 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -88.45 -30.04 19.73 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.357 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 38.0 m-80 -130.0 156.61 44.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.88 -7.39 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.942 0.877 . . . . 0.0 110.63 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.74 -21.72 60.12 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 63.3 mt-10 -84.24 126.02 32.76 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.26 132.1 44.44 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.397 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.25 114.32 7.39 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 122.164 0.983 . . . . 0.0 111.791 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 mt -87.0 104.79 16.64 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.322 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.67 120.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.613 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.93 121.04 12.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 -28.61 7.93 Favored Glycine 0 N--CA 1.427 -1.922 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.332 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.3 175.59 8.82 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.765 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -124.14 137.72 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.6 mt -109.28 130.71 61.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 121.136 0.493 . . . . 0.0 109.957 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.1 107.25 17.75 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.8 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.117 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.39 -59.64 2.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -164.22 157.67 18.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.5 139.59 30.54 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -106.48 -44.21 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.5 70.01 1.38 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.574 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 52.33 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.959 1.704 . . . . 0.0 113.585 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -71.5 -42.84 54.85 Favored Glycine 0 N--CA 1.419 -2.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.362 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -89.31 111.93 22.88 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.81 0.814 . . . . 0.0 111.949 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -101.2 164.27 11.87 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.788 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 m -124.78 120.62 32.28 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.946 0.403 . . . . 0.0 110.288 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.79 178.33 36.82 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -129.15 138.68 51.92 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.336 0.589 . . . . 0.0 110.827 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -111.01 101.03 9.62 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 68.39 -78.93 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.483 1.113 . . . . 0.0 113.068 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -131.14 -6.79 3.87 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -107.02 125.54 51.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.218 0.533 . . . . 0.0 110.923 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.18 136.53 37.56 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.28 -179.05 39.96 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 118.903 -1.618 . . . . 0.0 113.28 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 72.6 mt -99.17 137.71 37.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.63 141.54 22.96 Favored Pre-proline 0 C--N 1.291 -1.974 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.166 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 61.1 Cg_endo -78.71 128.88 8.86 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.378 2.052 . . . . 0.0 112.552 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 p -72.81 21.6 0.07 Allowed 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.152 1.381 . . . . 0.0 113.271 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 52' ' ' PRO . 26.6 t-20 -90.54 -42.71 10.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -90.27 -12.04 39.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.702 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 9' ' ' VAL . 32.6 m -121.6 140.07 46.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.976 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -121.39 141.71 50.71 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.744 0.307 . . . . 0.0 110.92 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -84.02 76.89 10.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -114.48 7.51 16.23 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.78 -174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--N 1.276 -2.587 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.048 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 m -71.68 121.74 19.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -8.09 57.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.275 . . . . 0.0 111.168 -175.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.23 4.19 Favored Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.726 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.12 13.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.57 135.89 43.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.626 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 25.7 p -111.48 152.39 27.5 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.971 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -100.49 144.9 28.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.69 109.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.56 -38.91 11.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 90.4 m-85 -127.75 156.24 42.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -99.34 162.44 13.04 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.843 -175.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HA ' ' A' ' 15' ' ' PRO . 41.3 t80 -137.38 124.05 21.06 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -91.53 105.6 13.64 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 18.4 Cg_endo -60.78 141.2 94.18 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.198 2.599 . . . . 0.0 112.671 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.2 -36.79 69.28 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.01 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 16.2 m-80 -129.39 161.87 29.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.97 4.36 19.81 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.68 -19.43 45.2 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.4 mp0 -86.03 139.26 31.32 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.037 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -75.16 129.67 37.92 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.0 109.01 2.81 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 122.22 1.009 . . . . 0.0 110.56 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 43.3 mt -84.34 112.96 20.8 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 113.726 -1.579 . . . . 0.0 108.494 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -111.64 126.55 69.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 12' ' ' ASP . 43.4 t -61.09 128.33 22.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 O-C-N 123.428 0.455 . . . . 0.0 111.183 -176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.71 -39.25 2.8 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.259 -0.972 . . . . 0.0 114.128 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -86.36 176.31 7.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.895 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.3 141.04 30.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 124.131 0.972 . . . . 0.0 109.319 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 74.8 mt -112.92 131.63 63.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.76 106.78 17.25 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -93.56 140.5 16.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.381 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -80.52 -64.8 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -173.56 170.16 4.16 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.38 127.98 32.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.07 -31.65 3.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.914 0.388 . . . . 0.0 111.38 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 43.8 mt-10 -137.89 168.31 19.95 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.77 91.89 1.97 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.373 0.606 . . . . 0.0 110.545 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 116.73 -11.76 15.55 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.938 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 90.6 m95 -117.89 116.95 27.98 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.352 0.596 . . . . 0.0 110.402 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -105.58 155.33 19.31 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 t -118.79 139.73 51.1 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.07 -172.26 44.79 Favored Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.7 t -130.53 146.1 51.99 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.79 -62.28 1.59 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -176.11 22.81 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.514 1.526 . . . . 0.0 107.295 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -172.11 -67.73 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.317 -169.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.87 120.03 25.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.83 133.25 53.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.48 -153.19 8.32 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.969 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.5 mm? -111.43 144.8 40.05 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -150.41 145.21 18.25 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-N 118.23 0.468 . . . . 0.0 111.3 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 54.7 Cg_endo -73.9 130.47 14.52 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.05 1.833 . . . . 0.0 110.766 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -78.99 17.34 0.76 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -75.05 -46.72 32.97 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.748 0.785 . . . . 0.0 109.173 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 54.8 m-85 -87.33 -6.95 58.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.084 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.02 142.32 38.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.853 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -122.27 128.82 51.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.0 109.94 7.9 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.526 0.73 . . . . 0.0 109.927 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mp 62.0 -173.15 0.15 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.665 0.786 . . . . 0.0 111.957 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -100.17 -28.25 13.11 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 117.348 0.574 . . . . 0.0 109.872 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.7 tpt -125.03 139.21 54.01 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.061 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.95 102.83 1.83 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' HD3' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -77.07 126.63 31.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -123.82 170.05 10.95 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.53 -170.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HG ' ' HB ' ' A' ' 29' ' ' ILE . 22.7 p -144.27 135.26 25.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.391 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.43 148.33 24.86 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 O-C-N 124.156 0.91 . . . . 0.0 110.976 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.43 -47.77 6.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.25 146.46 45.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.434 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.44 138.97 39.56 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.154 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 19.2 t80 -113.48 -59.44 2.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.257 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t 64.0 100.69 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -170.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 44.5 Cg_endo -61.51 158.95 33.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.594 2.196 . . . . 0.0 112.781 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -92.91 -39.87 10.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -115.06 -173.58 2.34 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.828 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -85.18 -13.49 49.89 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.51 -43.18 63.93 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.582 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.9 mp0 -72.34 147.8 45.95 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.951 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.12 147.72 28.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -71.76 109.57 5.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.937 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 43.6 mt -102.67 110.76 22.8 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.038 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.93 134.42 62.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.81 127.14 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.609 0.719 . . . . 0.0 112.116 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.26 -4.32 70.33 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.257 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -95.99 169.77 9.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 117.882 0.841 . . . . 0.0 109.567 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.32 139.43 51.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.508 0.67 . . . . 0.0 111.121 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 ' HB ' ' HG ' ' A' ' 7' ' ' CYS . 61.3 mt -115.4 138.22 46.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.127 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -94.3 93.18 7.58 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 5' ' ' ARG . 7.7 p -77.85 115.15 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.71 0.767 . . . . 0.0 110.467 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -71.24 -57.97 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.796 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -178.37 7.22 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.577 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -129.29 117.78 21.22 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.153 0.502 . . . . 0.0 111.386 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.2 -24.02 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.94 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -133.68 170.01 16.19 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.497 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.27 -45.9 24.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -84.58 -28.01 33.86 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.499 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.406 ' CZ3' ' HD3' ' A' ' 52' ' ' PRO . 91.7 m95 -115.24 117.28 30.06 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.494 0.664 . . . . 0.0 111.618 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -105.69 150.73 25.21 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 104.02 13.23 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.885 0.85 . . . . 0.0 110.797 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 167.42 24.37 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.962 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 t -114.09 131.49 56.38 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.08 -63.66 1.22 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.05 -72.12 0.7 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -123.64 -14.43 7.29 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.417 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -84.21 115.8 22.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.98 124.22 32.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.11 166.3 26.73 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 tp -97.72 138.18 35.48 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.29 149.9 33.19 Favored Pre-proline 0 C--N 1.295 -1.766 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.82 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 53.6 Cg_endo -71.34 122.01 8.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.715 2.277 . . . . 0.0 111.861 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 p -69.46 -10.64 58.9 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.774 0.83 . . . . 0.0 113.193 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.16 -15.48 60.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.737 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -101.99 7.01 41.47 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.363 -0.836 . . . . 0.0 112.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.67 167.22 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.88 145.97 48.77 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -85.55 144.64 27.79 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.238 0.542 . . . . 0.0 112.062 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.48 168.36 20.03 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.923 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.694 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.429 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -114.32 171.79 7.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.3 tpp -84.06 96.65 8.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.86 107.46 1.12 Allowed Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -88.75 -179.71 6.06 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 111.426 0.158 . . . . 0.0 111.426 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.452 ' O ' HD12 ' A' ' 59' ' ' LEU . 9.6 mt-30 -51.39 124.22 11.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 124.834 1.334 . . . . 0.0 108.676 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.7 p -83.24 131.44 35.1 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.031 -172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 57' ' ' LYS . 49.6 mttm -87.05 144.22 26.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.65 141.91 15.03 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' CD2' ' HD2' ' A' ' 57' ' ' LYS . 34.0 mt -99.94 -54.78 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 111.099 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -127.92 164.53 22.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.003 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.29 149.92 35.33 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.536 0.523 . . . . 0.0 110.856 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -146.75 113.43 6.03 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.5 t -103.84 108.0 58.4 Favored Pre-proline 0 N--CA 1.399 -3.021 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 29.2 Cg_endo -62.11 163.53 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.293 2.662 . . . . 0.0 112.732 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -92.87 -43.69 8.85 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -107.87 -173.14 2.21 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.14 15.64 25.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.24 0.543 . . . . 0.0 109.545 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.77 -36.77 13.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.371 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.3 mp0 -80.86 171.15 15.37 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 46.0 tp -106.24 139.81 40.17 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.4 164.17 26.79 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.573 0.701 . . . . 0.0 111.371 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.9 mt -133.27 124.39 27.24 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.28 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.44 123.78 68.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.09 116.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.453 0.644 . . . . 0.0 111.039 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.87 -8.96 29.71 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.398 -0.905 . . . . 0.0 112.966 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.33 177.88 5.81 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.15 134.38 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.515 0.726 . . . . 0.0 109.061 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -113.08 134.39 55.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.5 94.55 4.97 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.93 104.24 7.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.843 0.83 . . . . 0.0 109.136 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.2 mt -81.49 -58.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.186 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -138.55 169.27 18.1 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.457 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -115.96 137.51 52.05 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.68 -26.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.288 0.566 . . . . 0.0 110.489 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -138.07 178.15 7.34 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.91 -17.22 38.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.01 -1.36 20.82 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.523 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -136.13 124.63 23.54 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.018 0.437 . . . . 0.0 110.879 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.462 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 52.5 m0 -113.86 158.24 21.31 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.224 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -103.99 111.22 23.68 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.19 165.07 28.98 Favored Glycine 0 N--CA 1.424 -2.161 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.756 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 4.9 t -110.17 129.44 55.71 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -90.85 -74.74 0.49 Allowed 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.9 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.52 -21.68 12.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.245 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -165.9 -42.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.078 0.466 . . . . 0.0 110.441 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.8 mptm? -94.47 140.55 29.68 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.9 tp -90.43 101.36 14.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.801 -1.545 . . . . 0.0 106.948 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.17 177.29 18.59 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.794 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.6 mp -92.24 128.0 37.93 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.7 p90 -126.47 145.88 54.57 Favored Pre-proline 0 C--N 1.288 -2.082 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.687 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.48 113.11 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.614 2.209 . . . . 0.0 111.728 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.94 -24.44 62.53 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.875 1.27 . . . . 0.0 113.265 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.89 -22.33 64.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -99.39 16.19 23.91 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.818 -0.551 . . . . 0.0 111.959 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.49 162.15 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -119.42 126.2 50.78 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.161 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.01 133.25 40.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.88 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 6' ' ' GLN . 7.3 mp -96.88 129.89 44.25 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.566 0.222 . . . . 0.0 110.748 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 173.244 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.977 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m -81.26 91.61 6.23 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.264 0.554 . . . . 0.0 109.71 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp -92.87 -29.75 15.77 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.065 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.45 139.78 5.08 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.487 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -103.0 167.62 9.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.431 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.5 pt20 -50.29 135.83 20.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.891 0.853 . . . . 0.0 111.929 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.0 p -121.63 140.48 52.21 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.861 -172.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -93.61 154.39 17.87 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' A' ' 56' ' ' VAL . 48.6 t -82.12 129.87 36.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.527 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -96.14 -49.07 5.39 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.499 . . . . 0.0 109.848 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -130.8 147.88 52.51 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.63 135.41 45.49 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.499 0.5 . . . . 0.0 110.554 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.416 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 40.4 t80 -114.92 109.46 18.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -91.18 105.7 13.47 Favored Pre-proline 0 N--CA 1.403 -2.821 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 34.3 Cg_endo -68.47 163.2 37.58 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.055 2.503 . . . . 0.0 114.021 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.96 -33.1 39.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.205 1.002 . . . . 0.0 109.004 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -125.34 -168.5 1.84 Allowed 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -104.75 18.37 22.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.53 -47.01 13.65 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.149 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.7 mp0 -68.09 159.14 31.51 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 tp -80.87 125.72 30.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.58 122.77 20.36 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 122.015 0.912 . . . . 0.0 112.016 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.26 108.74 21.27 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.866 -1.515 . . . . 0.0 109.018 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 125.9 66.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.87 136.29 26.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.27 0.557 . . . . 0.0 110.558 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.02 -22.95 15.03 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.661 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.85 172.5 7.4 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.457 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.4 129.14 64.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 124.509 1.123 . . . . 0.0 108.802 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.51 132.65 60.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.11 105.67 17.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 12.8 p -86.71 148.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.209 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.1 -55.43 6.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.83 -176.32 1.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.18 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 11.9 pt-20 -107.39 141.66 38.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -96.46 -25.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.058 0.456 . . . . 0.0 110.779 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.33 151.98 38.38 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.86 94.23 0.82 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.648 0.737 . . . . 0.0 109.246 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 137.01 -23.13 3.22 Favored Glycine 0 N--CA 1.415 -2.713 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.905 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -124.75 114.8 19.76 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.609 0.719 . . . . 0.0 112.093 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.546 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 21.7 m0 -99.28 142.96 30.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.231 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -105.24 106.56 17.12 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 31' ' ' VAL . . . -145.98 167.73 27.72 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.28 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -111.79 131.23 55.47 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.656 0.741 . . . . 0.0 110.644 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.75 -34.51 69.55 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.246 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -164.27 -68.61 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.749 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.14 -16.23 6.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.03 110.23 20.46 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -89.55 131.22 35.68 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.6 174.92 35.73 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.339 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.14 136.36 37.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -142.64 145.14 32.97 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 56.2 Cg_endo -72.14 129.8 15.62 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 122.06 1.84 . . . . 0.0 112.17 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 5.6 p -79.24 15.34 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.495 ' OD1' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p-10 -95.1 -15.34 23.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.04 0.447 . . . . 0.0 109.887 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.22 6.74 28.92 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.051 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 9' ' ' VAL . 27.1 m -142.69 144.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -100.75 -107.64 0.22 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.294 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -171.03 145.85 2.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 6' ' ' GLN . 4.5 pp -99.78 166.68 10.97 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.318 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.283 -2.283 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.951 -174.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.2 t -103.41 -43.21 5.48 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 117.414 0.607 . . . . 0.0 109.475 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 tpt -148.87 162.57 39.57 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.52 -35.78 92.26 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 73.73 168.98 0.31 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.866 1.666 . . . . 0.0 112.894 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.518 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 45.4 mt-30 -137.33 -176.5 4.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 9.5 p -148.01 137.34 22.22 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.952 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HB2' ' HD3' ' A' ' 57' ' ' LYS . 3.5 mptp? -83.14 149.27 26.97 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.08 121.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.995 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.77 -47.04 7.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.0 110.897 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.82 146.53 45.62 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.54 162.22 22.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.067 0.461 . . . . 0.0 110.906 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -146.03 127.11 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.262 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 t -104.78 106.32 54.46 Favored Pre-proline 0 N--CA 1.416 -2.145 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.86 171.72 12.98 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 123.433 2.755 . . . . 0.0 114.445 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -86.71 -48.23 8.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.3 -177.83 3.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.969 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -85.86 -6.28 59.11 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.695 0.283 . . . . 0.0 110.393 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.14 -32.84 71.02 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.22 173.06 12.31 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.27 130.33 55.97 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.42 156.95 38.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 112.41 18.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.89 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mm -94.31 122.16 45.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.65 126.01 20.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.383 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 -15.44 63.34 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.054 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.26 -172.46 3.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.173 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.59 136.4 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 121.633 0.73 . . . . 0.0 111.672 -174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 75.0 mt -110.28 134.6 51.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.876 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.56 120.47 43.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.0 mt -88.14 -49.21 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -170.69 147.14 2.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.07 106.71 18.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.19 -40.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.038 -174.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -122.52 168.05 12.62 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.89 110.96 9.62 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 106.24 -26.7 19.53 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.264 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.56 114.48 28.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.413 0.625 . . . . 0.0 110.986 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -99.09 145.57 27.0 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.965 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -105.32 113.75 27.52 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.1 -177.62 27.7 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.296 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -133.14 129.37 37.79 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.5 tp -84.31 -65.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -104.05 -72.82 0.69 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -137.13 -5.44 1.87 Allowed 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.576 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -99.77 121.42 41.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.62 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 tt -77.64 128.17 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 169.5 32.85 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.81 132.76 36.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -139.87 144.92 40.47 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 58.1 Cg_endo -74.87 125.99 9.76 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.071 1.847 . . . . 0.0 111.851 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.9 p -60.45 -22.61 63.65 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.465 1.106 . . . . 0.0 112.499 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -58.27 -27.1 63.71 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.928 0.891 . . . . 0.0 112.4 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.63 -2.93 40.45 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.851 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 158.02 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 8' ' ' LYS . 19.0 ptmt -101.86 -11.6 18.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.143 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.74 174.02 0.27 Allowed 'General case' 0 CA--C 1.561 1.37 0 O-C-N 124.117 0.886 . . . . 0.0 108.779 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 6' ' ' GLN . 3.6 pp -143.39 177.65 8.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.406 -0.809 . . . . 0.0 110.338 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--N 1.293 -1.86 0 O-C-N 123.763 0.664 . . . . 0.0 109.5 -174.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -102.34 -10.24 19.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.864 0.332 . . . . 0.0 111.753 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 69.64 -74.45 0.08 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.793 1.237 . . . . 0.0 113.016 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.04 -165.44 12.02 Favored Glycine 0 C--N 1.296 -1.641 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -140.87 124.2 16.67 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -130.88 136.59 48.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.02 0.438 . . . . 0.0 110.779 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 26.7 p -114.92 152.54 32.12 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.828 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -107.6 149.8 27.62 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.764 0.316 . . . . 0.0 110.338 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.4 113.38 26.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.225 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 57' ' ' LYS . 57.7 mt -107.0 -38.92 5.9 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.887 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -107.57 159.47 16.42 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.77 148.6 24.23 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' HD11 ' A' ' 23' ' ' LEU . 9.5 t80 -114.57 -67.96 0.96 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.8 t 67.44 101.95 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -169.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.11 161.61 36.44 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.757 2.305 . . . . 0.0 113.321 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -87.29 -38.19 16.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.564 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 21.1 m120 -119.18 -175.45 2.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.865 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.82 -3.28 49.25 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.435 0.636 . . . . 0.0 109.577 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.56 -52.93 21.71 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.902 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.564 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -60.6 164.05 4.9 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.836 0.826 . . . . 0.0 111.615 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.4 tp -90.7 132.26 35.9 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.6 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.77 158.32 36.52 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-O 121.586 0.707 . . . . 0.0 110.078 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 13' ' ' TYR . 46.6 mt -123.98 101.21 7.12 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.229 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.11 120.43 38.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.1 t -63.67 124.66 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.864 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.03 -12.21 55.89 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.913 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.99 155.06 19.72 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.088 0.47 . . . . 0.0 111.889 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.31 135.78 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.53 119.55 60.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -82.53 117.16 22.33 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.96 143.9 15.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -88.8 -57.26 4.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.76 164.2 21.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -92.11 120.65 32.92 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.02 -29.23 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.635 0.731 . . . . 0.0 109.085 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 21.9 mm-40 -130.81 157.82 41.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -77.23 -26.85 53.05 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.727 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -90.06 -37.6 6.7 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.694 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -110.02 109.82 20.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.21 0.529 . . . . 0.0 110.772 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.587 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.0 m0 -94.35 163.98 13.2 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.225 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -115.37 114.29 24.91 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.088 0.471 . . . . 0.0 110.637 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.94 177.47 34.66 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -125.12 144.09 50.6 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.936 0.368 . . . . 0.0 110.108 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.38 -68.24 0.8 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -122.7 -49.5 2.0 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.05 -37.13 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.758 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.82 118.51 28.57 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.675 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -91.92 119.17 31.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.07 14.64 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.33 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.4 mp -100.24 146.18 27.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.764 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.09 147.03 22.52 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.545 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 51.4 Cg_endo -75.01 129.3 12.21 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.988 1.792 . . . . 0.0 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 p -75.52 21.09 0.15 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.404 1.082 . . . . 0.0 112.958 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -87.65 -44.06 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.388 0.613 . . . . 0.0 110.008 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.3 -7.53 56.6 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.265 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.21 146.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.317 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HD3' HD11 ' A' ' 10' ' ' LEU . 4.0 mptp? -127.38 144.93 50.98 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 173.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 30.0 tt0 -90.0 109.12 20.17 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.91 123.31 33.15 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.854 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.488 -178.278 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.19 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 t -80.51 95.78 6.59 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.4 mtp -99.62 107.39 19.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 111.019 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.35 -95.56 0.25 Allowed Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.501 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 60.94 3.89 0.72 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.127 1.371 . . . . 0.0 113.422 -176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.0 167.85 12.09 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.37 128.83 54.44 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -83.94 147.31 27.55 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.668 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.5 t -90.56 133.72 31.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 HD12 ' HD3' ' A' ' 57' ' ' LYS . 62.1 mt -95.1 -58.6 2.1 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.758 0.823 . . . . 0.0 109.526 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.12 160.18 24.24 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.088 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.4 158.58 24.58 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.166 0.508 . . . . 0.0 110.156 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.3 -58.3 2.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t 71.4 105.4 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.537 1.135 . . . . 0.0 109.105 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.23 154.86 43.45 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.279 1.986 . . . . 0.0 111.448 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -83.74 -29.46 27.45 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.463 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 13.2 m120 -112.13 -80.37 0.59 Allowed 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.504 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 167.6 -24.96 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.296 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.68 -21.72 61.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -74.7 150.98 39.28 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.12 117.65 20.35 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.973 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.18 126.75 28.72 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.342 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 51' ' ' PHE . 38.7 mt -91.9 117.02 29.4 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.47 114.11 28.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.228 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.76 127.08 26.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.348 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.97 -9.86 75.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.458 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.66 178.99 4.4 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.32 129.39 73.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.775 0.321 . . . . 0.0 110.926 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.86 141.08 15.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 123.535 0.734 . . . . 0.0 110.696 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.72 95.72 9.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.93 144.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.579 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.8 mt -113.74 -54.78 4.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.91 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -155.65 160.99 40.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 8.6 pt-20 -100.91 142.92 31.7 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 m -100.35 -25.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 44.7 mt-10 -139.11 164.82 28.78 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.03 -39.14 91.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 123.548 0.53 . . . . 0.0 110.16 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.83 -40.19 5.98 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.039 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -92.14 105.87 18.01 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.768 0.794 . . . . 0.0 111.638 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 43.6 m0 -93.74 153.49 18.3 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.014 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -109.7 120.5 42.69 Favored 'General case' 0 C--O 1.261 1.705 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.2 177.93 36.45 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -134.55 166.46 22.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.56 -60.53 0.79 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.36 0.6 . . . . 0.0 109.617 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -114.27 -69.74 0.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -128.22 -29.31 2.51 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.993 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -85.82 121.81 28.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.074 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 tp -98.93 107.01 19.33 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.75 -169.53 18.11 Favored Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 112.653 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 71.7 mt -96.93 146.22 25.16 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.837 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' HD22 ' A' ' 23' ' ' LEU . 44.1 p90 -147.42 147.5 28.38 Favored Pre-proline 0 C--N 1.299 -1.614 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.736 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.81 123.23 7.83 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.362 2.041 . . . . 0.0 111.701 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 56' ' ' VAL . 32.9 t -71.51 -10.96 60.57 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.24 -21.66 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.639 -0.663 . . . . 0.0 112.35 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.69 10.39 41.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.813 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 21.7 m -133.4 155.87 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.723 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 4.3 mptp? -122.45 126.43 47.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.554 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.05 24.99 0.73 Allowed 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.416 1.086 . . . . 0.0 111.89 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.09 133.51 49.75 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.981 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.286 -2.157 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.473 -179.737 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.828 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -156.8 -171.01 3.5 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ptm -74.76 84.52 2.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.342 1.068 . . . . 0.0 110.528 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.14 128.19 2.1 Favored Glycine 0 N--CA 1.403 -3.552 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -78.03 120.91 23.53 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -68.03 140.01 56.31 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.627 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.89 149.04 24.61 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.328 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -98.64 143.01 29.49 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.397 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 56' ' ' VAL . 21.6 t -84.97 108.03 16.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.957 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.36 -34.6 17.55 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.861 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.27 150.28 50.99 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.467 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -80.49 158.43 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.142 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -150.16 110.06 4.1 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.751 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -97.95 107.55 41.22 Favored Pre-proline 0 N--CA 1.411 -2.377 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.33 154.67 2.44 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 124.543 3.495 . . . . 0.0 114.457 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.13 -21.86 25.71 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.252 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -130.95 -161.72 1.15 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -105.18 7.05 33.52 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.527 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.49 -43.26 40.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.824 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.16 159.16 30.96 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.574 0.702 . . . . 0.0 111.041 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.61 143.78 28.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.91 120.57 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.1 mt -97.72 120.47 38.16 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.138 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.83 122.59 69.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.24 130.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 123.98 0.912 . . . . 0.0 112.827 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.25 -3.62 64.19 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.528 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.2 -178.48 3.67 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.18 138.74 53.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.694 0.798 . . . . 0.0 108.984 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.54 134.11 52.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.626 0.251 . . . . 0.0 110.452 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.65 96.7 4.9 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.51 129.54 36.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.256 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.7 mt -98.59 -61.35 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.5 176.81 6.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.7 pt-20 -108.32 128.3 54.62 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.983 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.97 -35.54 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.58 170.0 16.72 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.255 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.42 93.95 3.02 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.38 -35.79 3.1 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -99.84 114.18 27.19 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.334 0.588 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.9 m0 -99.66 158.37 15.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -111.99 120.38 41.69 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.23 33.85 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.536 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.9 m -105.92 128.37 53.74 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -81.25 -60.17 2.38 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -140.22 -65.72 0.45 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.033 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.83 -17.21 12.1 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.513 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -120.67 142.45 49.46 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.262 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 49' ' ' GLY . 5.7 tt -94.35 135.75 35.42 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' N ' HD22 ' A' ' 48' ' ' LEU . . . -150.45 170.2 30.36 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.068 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 69.5 mt -101.39 131.08 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -139.81 146.14 45.9 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.236 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.74 133.24 8.01 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.142 1.895 . . . . 0.0 111.366 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -80.44 42.58 0.6 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.781 0.801 . . . . 0.0 111.348 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -102.22 -40.56 6.72 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.22 -9.42 45.35 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 9' ' ' VAL . 35.9 m -127.01 140.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.734 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -124.6 142.08 51.62 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.628 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -84.15 99.69 10.67 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.88 153.77 48.32 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--N 1.29 -2.022 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.647 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.567 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -65.95 -54.68 23.14 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.178 0.591 . . . . 0.0 110.867 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.0 tpt -106.51 147.45 29.38 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.5 57.02 2.68 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 106.469 -2.652 . . . . 0.0 106.469 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER -57.85 135.93 56.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.653 -1.274 . . . . 0.0 108.079 -177.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 51.2 mt-30 -87.69 152.46 22.13 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.983 -172.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.7 p -120.74 155.94 32.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.258 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.6 mttm -105.72 140.13 39.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.572 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.79 118.79 26.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.139 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -101.82 -34.38 9.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.809 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -124.52 154.39 40.63 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.81 154.02 28.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -113.58 -52.46 2.75 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.624 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m 58.67 88.35 0.12 Allowed Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 110.487 -173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.19 153.46 39.39 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.05 2.5 . . . . 0.0 113.173 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.62 -17.68 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.73 -167.08 1.92 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.29 5.91 32.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.66 -31.18 16.72 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.225 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 2.8 mp0 -74.85 178.67 5.36 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.382 0.61 . . . . 0.0 110.134 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.7 tp -94.73 136.25 35.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -84.49 117.06 23.44 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.976 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 mt -89.96 108.42 19.71 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.696 -174.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.22 127.62 41.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.7 p -68.54 128.14 31.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 CA-C-O 121.803 0.811 . . . . 0.0 112.253 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.67 87.59 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.882 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 3.7 t0 -87.25 169.24 12.49 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.476 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.7 t -114.27 129.36 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.322 0.649 . . . . 0.0 110.709 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.31 134.83 53.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 122.972 0.509 . . . . 0.0 110.863 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 33.5 t70 -86.69 105.19 16.76 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 t -84.85 121.29 36.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.101 -176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -90.09 -50.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.76 152.86 18.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.158 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.9 pt-20 -90.1 124.43 34.8 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 168.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.49 -34.99 7.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.818 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -138.29 153.51 49.04 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -71.54 112.61 7.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.225 0.536 . . . . 0.0 109.856 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 110.32 -13.02 30.95 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.423 -177.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -126.7 107.02 9.79 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.38 0.609 . . . . 0.0 110.876 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.3 m0 -94.54 143.53 26.34 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -107.56 114.8 29.04 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.03 170.79 34.37 Favored Glycine 0 N--CA 1.42 -2.404 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -118.5 141.82 48.19 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.84 -54.92 4.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -132.54 -59.99 0.9 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.117 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.06 -21.6 2.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -101.91 115.64 30.98 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.955 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.97 108.54 5.94 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.83 173.2 16.56 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.954 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 18.1 tp -107.35 139.75 41.34 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -150.64 147.58 21.61 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 121.365 -0.134 . . . . 0.0 110.984 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 41.0 Cg_endo -71.3 129.45 15.99 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.089 1.859 . . . . 0.0 111.3 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -68.02 -22.29 64.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.7 0.8 . . . . 0.0 112.844 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -57.32 -33.06 67.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.964 0.506 . . . . 0.0 112.36 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -90.48 -6.66 54.57 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.402 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 27.3 m -118.48 137.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.229 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 13.5 mptt -116.19 131.87 56.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.802 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.21 116.13 20.94 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.995 -174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 6' ' ' GLN . 1.8 pt? -78.84 126.94 31.39 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--N 1.28 -2.425 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.99 -170.325 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 121.321 0.581 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.9 p -110.01 131.28 55.2 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.118 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 50.2 tttp -91.68 148.25 22.4 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 56' ' ' VAL . 43.1 t -88.22 114.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.02 -34.26 9.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 123.802 0.689 . . . . 0.0 111.513 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -121.79 160.68 24.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.271 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.71 131.18 35.26 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.601 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -131.46 113.01 13.19 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.214 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 31.6 m -94.1 106.75 24.18 Favored Pre-proline 0 N--CA 1.403 -2.783 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 37.1 Cg_endo -64.01 149.89 89.54 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.309 2.673 . . . . 0.0 113.836 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.45 -30.04 19.73 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.357 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 38.0 m-80 -130.0 156.61 44.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.88 -7.39 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.942 0.877 . . . . 0.0 110.63 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.74 -21.72 60.12 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 63.3 mt-10 -84.24 126.02 32.76 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.26 132.1 44.44 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.397 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.25 114.32 7.39 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 122.164 0.983 . . . . 0.0 111.791 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 mt -87.0 104.79 16.64 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.322 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.67 120.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.613 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.93 121.04 12.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 -28.61 7.93 Favored Glycine 0 N--CA 1.427 -1.922 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.332 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.3 175.59 8.82 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.765 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 14.1 p -124.14 137.72 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.6 mt -109.28 130.71 61.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 121.136 0.493 . . . . 0.0 109.957 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.1 107.25 17.75 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.8 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.117 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.39 -59.64 2.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -164.22 157.67 18.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.5 139.59 30.54 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -106.48 -44.21 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.5 70.01 1.38 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.574 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 52.33 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.959 1.704 . . . . 0.0 113.585 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -71.5 -42.84 54.85 Favored Glycine 0 N--CA 1.419 -2.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.362 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -89.31 111.93 22.88 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.81 0.814 . . . . 0.0 111.949 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -101.2 164.27 11.87 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.788 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 m -124.78 120.62 32.28 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.946 0.403 . . . . 0.0 110.288 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.79 178.33 36.82 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -129.15 138.68 51.92 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.336 0.589 . . . . 0.0 110.827 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -111.01 101.03 9.62 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 68.39 -78.93 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.483 1.113 . . . . 0.0 113.068 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -131.14 -6.79 3.87 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -107.02 125.54 51.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.218 0.533 . . . . 0.0 110.923 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.18 136.53 37.56 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.28 -179.05 39.96 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 118.903 -1.618 . . . . 0.0 113.28 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 72.6 mt -99.17 137.71 37.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.63 141.54 22.96 Favored Pre-proline 0 C--N 1.291 -1.974 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.166 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 61.1 Cg_endo -78.71 128.88 8.86 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.378 2.052 . . . . 0.0 112.552 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 p -72.81 21.6 0.07 Allowed 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.152 1.381 . . . . 0.0 113.271 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.54 -42.71 10.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -90.27 -12.04 39.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.702 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 9' ' ' VAL . 32.6 m -121.6 140.07 46.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.976 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -121.39 141.71 50.71 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.744 0.307 . . . . 0.0 110.92 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--N 1.308 -1.222 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.881 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 N--CA 1.443 -0.775 0 CA-C-O 121.333 0.587 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 25.7 p -111.48 152.39 27.5 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.971 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -100.49 144.9 28.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.69 109.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.56 -38.91 11.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 90.4 m-85 -127.75 156.24 42.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -99.34 162.44 13.04 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.843 -175.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 15' ' ' PRO . 41.3 t80 -137.38 124.05 21.06 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 22.9 t -91.53 105.6 13.64 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 18.4 Cg_endo -60.78 141.2 94.18 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.198 2.599 . . . . 0.0 112.671 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.2 -36.79 69.28 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.01 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 16.2 m-80 -129.39 161.87 29.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.97 4.36 19.81 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.68 -19.43 45.2 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.4 mp0 -86.03 139.26 31.32 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.037 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -75.16 129.67 37.92 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.0 109.01 2.81 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 122.22 1.009 . . . . 0.0 110.56 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 43.3 mt -84.34 112.96 20.8 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 113.726 -1.579 . . . . 0.0 108.494 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -111.64 126.55 69.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 12' ' ' ASP . 43.4 t -61.09 128.33 22.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 O-C-N 123.428 0.455 . . . . 0.0 111.183 -176.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.71 -39.25 2.8 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.259 -0.972 . . . . 0.0 114.128 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -86.36 176.31 7.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.895 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.3 141.04 30.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 124.131 0.972 . . . . 0.0 109.319 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 74.8 mt -112.92 131.63 63.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.76 106.78 17.25 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -93.56 140.5 16.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.381 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -80.52 -64.8 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -173.56 170.16 4.16 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 12.7 pt-20 -78.38 127.98 32.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.07 -31.65 3.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.914 0.388 . . . . 0.0 111.38 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 43.8 mt-10 -137.89 168.31 19.95 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.77 91.89 1.97 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.373 0.606 . . . . 0.0 110.545 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 116.73 -11.76 15.55 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.938 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 90.6 m95 -117.89 116.95 27.98 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.352 0.596 . . . . 0.0 110.402 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 40.1 m0 -105.58 155.33 19.31 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 t -118.79 139.73 51.1 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.07 -172.26 44.79 Favored Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.7 t -130.53 146.1 51.99 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.79 -62.28 1.59 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -176.11 22.81 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.514 1.526 . . . . 0.0 107.295 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -172.11 -67.73 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.317 -169.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.87 120.03 25.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.83 133.25 53.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.48 -153.19 8.32 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.969 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.5 mm? -111.43 144.8 40.05 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -150.41 145.21 18.25 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-N 118.23 0.468 . . . . 0.0 111.3 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 54.7 Cg_endo -73.9 130.47 14.52 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.05 1.833 . . . . 0.0 110.766 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -78.99 17.34 0.76 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -75.05 -46.72 32.97 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.748 0.785 . . . . 0.0 109.173 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 54.8 m-85 -87.33 -6.95 58.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.084 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.02 142.32 38.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.853 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -122.27 128.82 51.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 123.526 0.73 . . . . 0.0 109.927 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 90.4 mt-30 . . . . . 0 CA--C 1.506 -0.744 0 CA-C-O 120.582 0.229 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.7 p -144.27 135.26 25.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.391 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.43 148.33 24.86 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 O-C-N 124.156 0.91 . . . . 0.0 110.976 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.43 -47.77 6.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.25 146.46 45.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.434 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.44 138.97 39.56 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.154 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 19.2 t80 -113.48 -59.44 2.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.257 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t 64.0 100.69 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -170.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 44.5 Cg_endo -61.51 158.95 33.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.594 2.196 . . . . 0.0 112.781 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -92.91 -39.87 10.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -115.06 -173.58 2.34 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.828 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -85.18 -13.49 49.89 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.51 -43.18 63.93 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.582 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.9 mp0 -72.34 147.8 45.95 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.951 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.12 147.72 28.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -71.76 109.57 5.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.937 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 43.6 mt -102.67 110.76 22.8 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.038 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.93 134.42 62.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.81 127.14 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.609 0.719 . . . . 0.0 112.116 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.26 -4.32 70.33 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.257 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -95.99 169.77 9.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 117.882 0.841 . . . . 0.0 109.567 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.32 139.43 51.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.508 0.67 . . . . 0.0 111.121 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.4 138.22 46.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.127 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 11.2 t70 -94.3 93.18 7.58 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.85 115.15 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.71 0.767 . . . . 0.0 110.467 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 48' ' ' LEU . 50.6 mt -71.24 -57.97 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.796 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -178.37 7.22 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.577 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -129.29 117.78 21.22 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.153 0.502 . . . . 0.0 111.386 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.2 -24.02 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.94 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -133.68 170.01 16.19 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.497 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.27 -45.9 24.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -84.58 -28.01 33.86 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.499 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.405 ' CZ3' ' HD3' ' A' ' 52' ' ' PRO . 91.7 m95 -115.24 117.28 30.06 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.494 0.664 . . . . 0.0 111.618 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -105.69 150.73 25.21 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 104.02 13.23 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.885 0.85 . . . . 0.0 110.797 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 167.42 24.37 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.962 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 t -114.09 131.49 56.38 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.08 -63.66 1.22 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -119.05 -72.12 0.7 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -123.64 -14.43 7.29 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.417 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -84.21 115.8 22.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 HD12 ' A' ' 32' ' ' ILE . 64.6 tp -85.98 124.22 32.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.11 166.3 26.73 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 tp -97.72 138.18 35.48 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.29 149.9 33.19 Favored Pre-proline 0 C--N 1.295 -1.766 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.82 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 53.6 Cg_endo -71.34 122.01 8.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.715 2.277 . . . . 0.0 111.861 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 p -69.46 -10.64 58.9 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.774 0.83 . . . . 0.0 113.193 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.16 -15.48 60.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.737 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -101.99 7.01 41.47 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.363 -0.836 . . . . 0.0 112.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.67 167.22 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.88 145.97 48.77 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 . . . . . 0 C--N 1.295 -1.791 0 CA-C-O 121.238 0.542 . . . . 0.0 112.062 -175.431 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 . . . . . 0 C--O 1.241 0.623 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.7 p -83.24 131.44 35.1 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.031 -172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.42 ' O ' ' HD3' ' A' ' 57' ' ' LYS . 49.6 mttm -87.05 144.22 26.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.65 141.91 15.03 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' CD2' ' HD2' ' A' ' 57' ' ' LYS . 34.0 mt -99.94 -54.78 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 111.099 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -127.92 164.53 22.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.003 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.29 149.92 35.33 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.536 0.523 . . . . 0.0 110.856 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 79.8 t80 -146.75 113.43 6.03 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 26.5 t -103.84 108.0 58.4 Favored Pre-proline 0 N--CA 1.399 -3.021 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 29.2 Cg_endo -62.11 163.53 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.293 2.662 . . . . 0.0 112.732 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -92.87 -43.69 8.85 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -107.87 -173.14 2.21 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.14 15.64 25.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.24 0.543 . . . . 0.0 109.545 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.77 -36.77 13.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.371 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.3 mp0 -80.86 171.15 15.37 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 46.0 tp -106.24 139.81 40.17 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.4 164.17 26.79 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.573 0.701 . . . . 0.0 111.371 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 72.9 mt -133.27 124.39 27.24 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.28 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.44 123.78 68.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.09 116.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.453 0.644 . . . . 0.0 111.039 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.87 -8.96 29.71 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.398 -0.905 . . . . 0.0 112.966 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.33 177.88 5.81 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.15 134.38 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.515 0.726 . . . . 0.0 109.061 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -113.08 134.39 55.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.5 94.55 4.97 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.93 104.24 7.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.843 0.83 . . . . 0.0 109.136 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 33' ' ' GLU . 65.2 mt -81.49 -58.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.186 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 32' ' ' ILE . 20.8 mm-40 -138.55 169.27 18.1 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.457 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -115.96 137.51 52.05 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.68 -26.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.288 0.566 . . . . 0.0 110.489 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -138.07 178.15 7.34 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -84.91 -17.22 38.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.01 -1.36 20.82 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.523 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -136.13 124.63 23.54 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.018 0.437 . . . . 0.0 110.879 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 52.5 m0 -113.86 158.24 21.31 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.224 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -103.99 111.22 23.68 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.19 165.07 28.98 Favored Glycine 0 N--CA 1.424 -2.161 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.756 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 4.9 t -110.17 129.44 55.71 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -90.85 -74.74 0.49 Allowed 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.9 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.52 -21.68 12.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.245 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -165.9 -42.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.078 0.466 . . . . 0.0 110.441 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.8 mptm? -94.47 140.55 29.68 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.9 tp -90.43 101.36 14.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.801 -1.545 . . . . 0.0 106.948 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.17 177.29 18.59 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.794 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.6 mp -92.24 128.0 37.93 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.7 p90 -126.47 145.88 54.57 Favored Pre-proline 0 C--N 1.288 -2.082 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.687 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.48 113.11 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.614 2.209 . . . . 0.0 111.728 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.94 -24.44 62.53 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.875 1.27 . . . . 0.0 113.265 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.89 -22.33 64.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -99.39 16.19 23.91 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.818 -0.551 . . . . 0.0 111.959 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.49 162.15 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -119.42 126.2 50.78 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.161 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.88 178.757 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.243 0.725 0 CA-C-O 121.891 0.853 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.0 p -121.63 140.48 52.21 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.861 -172.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -93.61 154.39 17.87 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 56' ' ' VAL . 48.6 t -82.12 129.87 36.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.527 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -96.14 -49.07 5.39 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.499 . . . . 0.0 109.848 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -130.8 147.88 52.51 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.63 135.41 45.49 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.499 0.5 . . . . 0.0 110.554 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 40.4 t80 -114.92 109.46 18.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -91.18 105.7 13.47 Favored Pre-proline 0 N--CA 1.403 -2.821 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 34.3 Cg_endo -68.47 163.2 37.58 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.055 2.503 . . . . 0.0 114.021 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.96 -33.1 39.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.205 1.002 . . . . 0.0 109.004 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -125.34 -168.5 1.84 Allowed 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -104.75 18.37 22.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.53 -47.01 13.65 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.149 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.7 mp0 -68.09 159.14 31.51 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 tp -80.87 125.72 30.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.58 122.77 20.36 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 122.015 0.912 . . . . 0.0 112.016 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 47.0 mt -96.26 108.74 21.27 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.866 -1.515 . . . . 0.0 109.018 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 125.9 66.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.87 136.29 26.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.27 0.557 . . . . 0.0 110.558 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.02 -22.95 15.03 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.661 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.85 172.5 7.4 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.457 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.4 129.14 64.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 124.509 1.123 . . . . 0.0 108.802 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.51 132.65 60.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.11 105.67 17.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 12.8 p -86.71 148.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.209 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.1 -55.43 6.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.83 -176.32 1.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.18 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 11.9 pt-20 -107.39 141.66 38.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -96.46 -25.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.058 0.456 . . . . 0.0 110.779 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.33 151.98 38.38 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.86 94.23 0.82 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.648 0.737 . . . . 0.0 109.246 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 137.01 -23.13 3.22 Favored Glycine 0 N--CA 1.415 -2.713 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.905 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -124.75 114.8 19.76 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.609 0.719 . . . . 0.0 112.093 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 21.7 m0 -99.28 142.96 30.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.231 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -105.24 106.56 17.12 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 31' ' ' VAL . . . -145.98 167.73 27.72 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.28 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -111.79 131.23 55.47 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.656 0.741 . . . . 0.0 110.644 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.75 -34.51 69.55 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.246 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -164.27 -68.61 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.749 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.14 -16.23 6.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.03 110.23 20.46 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -89.55 131.22 35.68 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.6 174.92 35.73 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.339 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.14 136.36 37.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -142.64 145.14 32.97 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 56.2 Cg_endo -72.14 129.8 15.62 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 122.06 1.84 . . . . 0.0 112.17 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 5.6 p -79.24 15.34 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p-10 -95.1 -15.34 23.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.04 0.447 . . . . 0.0 109.887 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.22 6.74 28.92 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.051 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 9' ' ' VAL . 27.1 m -142.69 144.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 58' ' ' GLU . 11.4 ptmt -100.75 -107.64 0.22 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.294 172.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' LYS . 40.5 tt0 . . . . . 0 C--N 1.296 -1.751 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 9.5 p -148.01 137.34 22.22 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.952 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HB2' ' HD3' ' A' ' 57' ' ' LYS . 3.5 mptp? -83.14 149.27 26.97 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 23' ' ' LEU . 61.0 t -97.08 121.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.995 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.77 -47.04 7.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.0 110.897 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.82 146.53 45.62 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.54 162.22 22.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.067 0.461 . . . . 0.0 110.906 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -146.03 127.11 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.262 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 t -104.78 106.32 54.46 Favored Pre-proline 0 N--CA 1.416 -2.145 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 37.1 Cg_endo -68.86 171.72 12.98 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 123.433 2.755 . . . . 0.0 114.445 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -86.71 -48.23 8.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.3 -177.83 3.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.969 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -85.86 -6.28 59.11 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.695 0.283 . . . . 0.0 110.393 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.14 -32.84 71.02 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.6 mp0 -77.22 173.06 12.31 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.27 130.33 55.97 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.42 156.95 38.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' HG11 ' A' ' 9' ' ' VAL . 51.9 mt -120.79 112.41 18.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.89 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mm -94.31 122.16 45.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.65 126.01 20.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.383 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 -15.44 63.34 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.054 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.26 -172.46 3.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.173 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.59 136.4 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 121.633 0.73 . . . . 0.0 111.672 -174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 75.0 mt -110.28 134.6 51.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.876 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.56 120.47 43.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.0 mt -88.14 -49.21 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -170.69 147.14 2.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.3 pt-20 -90.07 106.71 18.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.19 -40.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.038 -174.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 61.5 mm-40 -122.52 168.05 12.62 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.89 110.96 9.62 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 106.24 -26.7 19.53 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.264 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 95.5 m95 -108.56 114.48 28.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.413 0.625 . . . . 0.0 110.986 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 44.3 m0 -99.09 145.57 27.0 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.965 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -105.32 113.75 27.52 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.1 -177.62 27.7 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.296 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -133.14 129.37 37.79 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.5 tp -84.31 -65.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -104.05 -72.82 0.69 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -137.13 -5.44 1.87 Allowed 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.576 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -99.77 121.42 41.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.62 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 tt -77.64 128.17 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 169.5 32.85 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.81 132.76 36.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -139.87 144.92 40.47 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 58.1 Cg_endo -74.87 125.99 9.76 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.071 1.847 . . . . 0.0 111.851 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 56' ' ' VAL . 15.9 p -60.45 -22.61 63.65 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.465 1.106 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -58.27 -27.1 63.71 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.928 0.891 . . . . 0.0 112.4 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.63 -2.93 40.45 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.851 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 53' ' ' SER . 34.1 m -113.48 158.02 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 8' ' ' LYS . 19.0 ptmt -101.86 -11.6 18.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.143 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 CA--C 1.561 1.37 0 O-C-N 124.117 0.886 . . . . 0.0 108.779 -175.741 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 80.5 mt-30 . . . . . 0 CA--C 1.509 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 26.7 p -114.92 152.54 32.12 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.828 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -107.6 149.8 27.62 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.764 0.316 . . . . 0.0 110.338 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 41.8 t -91.4 113.38 26.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.225 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.471 HD12 ' HD3' ' A' ' 57' ' ' LYS . 57.7 mt -107.0 -38.92 5.9 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.887 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -107.57 159.47 16.42 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.77 148.6 24.23 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.5 t80 -114.57 -67.96 0.96 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.8 t 67.44 101.95 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -169.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.11 161.61 36.44 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.757 2.305 . . . . 0.0 113.321 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -87.29 -38.19 16.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.57 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 21.1 m120 -119.18 -175.45 2.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.865 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.82 -3.28 49.25 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.435 0.636 . . . . 0.0 109.577 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.56 -52.93 21.71 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.902 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.57 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -60.6 164.05 4.9 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.836 0.826 . . . . 0.0 111.615 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.4 tp -90.7 132.26 35.9 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.6 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.77 158.32 36.52 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-O 121.586 0.707 . . . . 0.0 110.078 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 13' ' ' TYR . 46.6 mt -123.98 101.21 7.12 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.229 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.11 120.43 38.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.1 t -63.67 124.66 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.864 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.03 -12.21 55.89 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.913 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.99 155.06 19.72 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.088 0.47 . . . . 0.0 111.889 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.31 135.78 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.53 119.55 60.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 29.4 t70 -82.53 117.16 22.33 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.96 143.9 15.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -88.8 -57.26 4.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.76 164.2 21.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -92.11 120.65 32.92 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.02 -29.23 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.635 0.731 . . . . 0.0 109.085 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 21.9 mm-40 -130.81 157.82 41.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -77.23 -26.85 53.05 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.727 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -90.06 -37.6 6.7 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.694 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -110.02 109.82 20.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.21 0.529 . . . . 0.0 110.772 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.0 m0 -94.35 163.98 13.2 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.225 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -115.37 114.29 24.91 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.088 0.471 . . . . 0.0 110.637 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.94 177.47 34.66 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -125.12 144.09 50.6 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.936 0.368 . . . . 0.0 110.108 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.38 -68.24 0.8 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -122.7 -49.5 2.0 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.05 -37.13 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.758 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.82 118.51 28.57 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.675 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -91.92 119.17 31.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.07 14.64 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.33 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.4 mp -100.24 146.18 27.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.764 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.09 147.03 22.52 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.545 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 51.4 Cg_endo -75.01 129.3 12.21 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.988 1.792 . . . . 0.0 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 p -75.52 21.09 0.15 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.404 1.082 . . . . 0.0 112.958 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -87.65 -44.06 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.388 0.613 . . . . 0.0 110.008 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.3 -7.53 56.6 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.265 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 9' ' ' VAL . 30.4 m -123.21 146.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.317 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' A' ' 10' ' ' LEU . 4.0 mptp? -127.38 144.93 50.98 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 173.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 30.0 tt0 . . . . . 0 N--CA 1.416 -2.135 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.37 128.83 54.44 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -83.94 147.31 27.55 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.668 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.5 t -90.56 133.72 31.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HD3' ' A' ' 57' ' ' LYS . 62.1 mt -95.1 -58.6 2.1 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.758 0.823 . . . . 0.0 109.526 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.12 160.18 24.24 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.088 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.4 158.58 24.58 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.166 0.508 . . . . 0.0 110.156 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.3 -58.3 2.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t 71.4 105.4 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.537 1.135 . . . . 0.0 109.105 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.23 154.86 43.45 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.279 1.986 . . . . 0.0 111.448 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -83.74 -29.46 27.45 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.475 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 89.2 m-20 -112.13 -80.37 0.59 Allowed 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.504 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 167.6 -24.96 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.296 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.68 -21.72 61.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.475 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -74.7 150.98 39.28 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.12 117.65 20.35 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.973 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.18 126.75 28.72 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.342 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 51' ' ' PHE . 38.7 mt -91.9 117.02 29.4 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.47 114.11 28.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.228 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.76 127.08 26.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.348 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.97 -9.86 75.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.458 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.66 178.99 4.4 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.32 129.39 73.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.775 0.321 . . . . 0.0 110.926 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.86 141.08 15.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 123.535 0.734 . . . . 0.0 110.696 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.72 95.72 9.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.93 144.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.579 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.8 mt -113.74 -54.78 4.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.91 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -155.65 160.99 40.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 8.6 pt-20 -100.91 142.92 31.7 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 m -100.35 -25.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 44.7 mt-10 -139.11 164.82 28.78 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.03 -39.14 91.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 123.548 0.53 . . . . 0.0 110.16 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.83 -40.19 5.98 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.039 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -92.14 105.87 18.01 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.768 0.794 . . . . 0.0 111.638 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 43.6 m0 -93.74 153.49 18.3 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.014 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -109.7 120.5 42.69 Favored 'General case' 0 C--O 1.261 1.705 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.2 177.93 36.45 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -134.55 166.46 22.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.56 -60.53 0.79 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.36 0.6 . . . . 0.0 109.617 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -114.27 -69.74 0.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -128.22 -29.31 2.51 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.993 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -85.82 121.81 28.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.074 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 tp -98.93 107.01 19.33 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.75 -169.53 18.11 Favored Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 112.653 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 71.7 mt -96.93 146.22 25.16 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.837 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 23' ' ' LEU . 44.1 p90 -147.42 147.5 28.38 Favored Pre-proline 0 C--N 1.299 -1.614 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.736 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.81 123.23 7.83 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.362 2.041 . . . . 0.0 111.701 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 56' ' ' VAL . 32.9 t -71.51 -10.96 60.57 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.24 -21.66 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.639 -0.663 . . . . 0.0 112.35 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.69 10.39 41.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.813 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 53' ' ' SER . 21.7 m -133.4 155.87 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.723 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' A' ' 10' ' ' LEU . 4.3 mptp? -122.45 126.43 47.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.554 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--N 1.312 -1.04 0 C-N-CA 124.416 1.086 . . . . 0.0 111.89 -175.127 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.89 149.04 24.61 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.328 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -98.64 143.01 29.49 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.397 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 56' ' ' VAL . 21.6 t -84.97 108.03 16.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.957 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.36 -34.6 17.55 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.861 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.27 150.28 50.99 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.467 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -80.49 158.43 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.142 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -150.16 110.06 4.1 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.751 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -97.95 107.55 41.22 Favored Pre-proline 0 N--CA 1.411 -2.377 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 63.4 Cg_exo -48.33 154.67 2.44 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 124.543 3.495 . . . . 0.0 114.457 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.13 -21.86 25.71 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.252 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 91.2 m-20 -130.95 -161.72 1.15 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -105.18 7.05 33.52 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.527 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.49 -43.26 40.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.824 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.16 159.16 30.96 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.574 0.702 . . . . 0.0 111.041 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.61 143.78 28.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 20.3 mt-10 -81.91 120.57 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.1 mt -97.72 120.47 38.16 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.138 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.83 122.59 69.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.24 130.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 123.98 0.912 . . . . 0.0 112.827 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.25 -3.62 64.19 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.528 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.2 -178.48 3.67 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.18 138.74 53.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.694 0.798 . . . . 0.0 108.984 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.54 134.11 52.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.626 0.251 . . . . 0.0 110.452 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.65 96.7 4.9 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.51 129.54 36.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.256 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.7 mt -98.59 -61.35 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.5 176.81 6.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.7 pt-20 -108.32 128.3 54.62 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.983 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.97 -35.54 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.58 170.0 16.72 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.255 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.42 93.95 3.02 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.38 -35.79 3.1 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -99.84 114.18 27.19 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.334 0.588 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.9 m0 -99.66 158.37 15.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -111.99 120.38 41.69 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.23 33.85 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.536 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.9 m -105.92 128.37 53.74 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -81.25 -60.17 2.38 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -140.22 -65.72 0.45 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.033 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.83 -17.21 12.1 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.513 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -120.67 142.45 49.46 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.262 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 49' ' ' GLY . 5.7 tt -94.35 135.75 35.42 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 48' ' ' LEU . . . -150.45 170.2 30.36 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.068 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 69.5 mt -101.39 131.08 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -139.81 146.14 45.9 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.236 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.74 133.24 8.01 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.142 1.895 . . . . 0.0 111.366 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -80.44 42.58 0.6 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.781 0.801 . . . . 0.0 111.348 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -102.22 -40.56 6.72 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.22 -9.42 45.35 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 9' ' ' VAL . 35.9 m -127.01 140.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.734 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -124.6 142.08 51.62 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.628 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.378 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 51.2 mt-30 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-O 120.862 0.363 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.7 p -120.74 155.94 32.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.258 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.6 mttm -105.72 140.13 39.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.572 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 23' ' ' LEU . 99.8 t -78.79 118.79 26.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.139 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -101.82 -34.38 9.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.809 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -124.52 154.39 40.63 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.81 154.02 28.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -113.58 -52.46 2.75 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.624 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m 58.67 88.35 0.12 Allowed Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 110.487 -173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.19 153.46 39.39 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.05 2.5 . . . . 0.0 113.173 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -90.62 -17.68 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.73 -167.08 1.92 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -105.29 5.91 32.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.66 -31.18 16.72 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.225 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 2.8 mp0 -74.85 178.67 5.36 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.382 0.61 . . . . 0.0 110.134 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.7 tp -94.73 136.25 35.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -84.49 117.06 23.44 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.976 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 9' ' ' VAL . 26.7 mt -89.96 108.42 19.71 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.696 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.22 127.62 41.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.7 p -68.54 128.14 31.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 CA-C-O 121.803 0.811 . . . . 0.0 112.253 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.67 87.59 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.882 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 3.7 t0 -87.25 169.24 12.49 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.476 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.7 t -114.27 129.36 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.322 0.649 . . . . 0.0 110.709 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.31 134.83 53.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 122.972 0.509 . . . . 0.0 110.863 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 33.5 t70 -86.69 105.19 16.76 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 t -84.85 121.29 36.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.101 -176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -90.09 -50.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.76 152.86 18.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.158 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.9 pt-20 -90.1 124.43 34.8 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 168.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.49 -34.99 7.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.818 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -138.29 153.51 49.04 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -71.54 112.61 7.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.225 0.536 . . . . 0.0 109.856 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 110.32 -13.02 30.95 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.423 -177.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -126.7 107.02 9.79 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.38 0.609 . . . . 0.0 110.876 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.3 m0 -94.54 143.53 26.34 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -107.56 114.8 29.04 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.03 170.79 34.37 Favored Glycine 0 N--CA 1.42 -2.404 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -118.5 141.82 48.19 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.84 -54.92 4.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -132.54 -59.99 0.9 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.117 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.06 -21.6 2.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -101.91 115.64 30.98 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.955 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.97 108.54 5.94 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.83 173.2 16.56 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.954 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 18.1 tp -107.35 139.75 41.34 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -150.64 147.58 21.61 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 121.365 -0.134 . . . . 0.0 110.984 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 41.0 Cg_endo -71.3 129.45 15.99 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.089 1.859 . . . . 0.0 111.3 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -68.02 -22.29 64.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.7 0.8 . . . . 0.0 112.844 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -57.32 -33.06 67.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.964 0.506 . . . . 0.0 112.36 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -90.48 -6.66 54.57 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 27.3 m -118.48 137.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.229 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 13.5 mptt -116.19 131.87 56.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.802 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--N 1.293 -1.874 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.995 -174.456 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.445 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -100.66 -6.24 25.45 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.416 -0.461 . . . . 0.0 111.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.6 mmt 60.87 38.82 17.56 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.96 141.39 45.22 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.234 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -102.54 159.29 15.57 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.312 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -68.72 141.33 55.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.905 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.9 p -110.01 131.28 55.2 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.118 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 50.2 tttp -91.68 148.25 22.4 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 56' ' ' VAL . 43.1 t -88.22 114.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.02 -34.26 9.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 123.802 0.689 . . . . 0.0 111.513 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -121.79 160.68 24.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.271 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.71 131.18 35.26 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.601 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -131.46 113.01 13.19 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.214 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 31.6 m -94.1 106.75 24.18 Favored Pre-proline 0 N--CA 1.403 -2.783 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 37.1 Cg_endo -64.01 149.89 89.54 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.309 2.673 . . . . 0.0 113.836 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -88.45 -30.04 19.73 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.357 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 38.0 m-80 -130.0 156.61 44.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.88 -7.39 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.942 0.877 . . . . 0.0 110.63 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.74 -21.72 60.12 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 63.3 mt-10 -84.24 126.02 32.76 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.26 132.1 44.44 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.397 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.25 114.32 7.39 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 122.164 0.983 . . . . 0.0 111.791 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 mt -87.0 104.79 16.64 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.322 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.67 120.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.613 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.93 121.04 12.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 -28.61 7.93 Favored Glycine 0 N--CA 1.427 -1.922 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.332 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.3 175.59 8.82 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.765 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 14.1 p -124.14 137.72 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.6 mt -109.28 130.71 61.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 121.136 0.493 . . . . 0.0 109.957 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.1 107.25 17.75 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.8 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.117 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.39 -59.64 2.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -164.22 157.67 18.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.5 139.59 30.54 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -106.48 -44.21 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.5 70.01 1.38 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.574 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 52.33 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.959 1.704 . . . . 0.0 113.585 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -71.5 -42.84 54.85 Favored Glycine 0 N--CA 1.419 -2.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.362 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -89.31 111.93 22.88 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.81 0.814 . . . . 0.0 111.949 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -101.2 164.27 11.87 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.788 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 m -124.78 120.62 32.28 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.946 0.403 . . . . 0.0 110.288 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.79 178.33 36.82 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -129.15 138.68 51.92 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.336 0.589 . . . . 0.0 110.827 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -111.01 101.03 9.62 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 68.39 -78.93 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.483 1.113 . . . . 0.0 113.068 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -131.14 -6.79 3.87 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -107.02 125.54 51.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.218 0.533 . . . . 0.0 110.923 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.18 136.53 37.56 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.28 -179.05 39.96 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 118.903 -1.618 . . . . 0.0 113.28 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 72.6 mt -99.17 137.71 37.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.63 141.54 22.96 Favored Pre-proline 0 C--N 1.291 -1.974 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.166 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 61.1 Cg_endo -78.71 128.88 8.86 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.378 2.052 . . . . 0.0 112.552 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 p -72.81 21.6 0.07 Allowed 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.152 1.381 . . . . 0.0 113.271 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.54 -42.71 10.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -90.27 -12.04 39.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.702 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 9' ' ' VAL . 32.6 m -121.6 140.07 46.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.976 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -121.39 141.71 50.71 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.744 0.307 . . . . 0.0 110.92 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -84.02 76.89 10.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 59' ' ' LEU . 1.8 pt? -114.48 7.51 16.23 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.78 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--N 1.276 -2.587 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.048 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 m -71.68 121.74 19.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -8.09 57.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.275 . . . . 0.0 111.168 -175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.23 4.19 Favored Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.726 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.12 13.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -73.57 135.89 43.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.626 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 25.7 p -111.48 152.39 27.5 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.971 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -100.49 144.9 28.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.69 109.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.56 -38.91 11.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 90.4 m-85 -127.75 156.24 42.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -99.34 162.44 13.04 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.843 -175.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 15' ' ' PRO . 41.3 t80 -137.38 124.05 21.06 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 22.9 t -91.53 105.6 13.64 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 18.4 Cg_endo -60.78 141.2 94.18 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.198 2.599 . . . . 0.0 112.671 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.2 -36.79 69.28 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.01 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 16.2 m-80 -129.39 161.87 29.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.97 4.36 19.81 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.68 -19.43 45.2 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.4 mp0 -86.03 139.26 31.32 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.037 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -75.16 129.67 37.92 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.0 109.01 2.81 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 122.22 1.009 . . . . 0.0 110.56 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 43.3 mt -84.34 112.96 20.8 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 113.726 -1.579 . . . . 0.0 108.494 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -111.64 126.55 69.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 12' ' ' ASP . 43.4 t -61.09 128.33 22.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 O-C-N 123.428 0.455 . . . . 0.0 111.183 -176.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.71 -39.25 2.8 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.259 -0.972 . . . . 0.0 114.128 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -86.36 176.31 7.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.895 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.3 141.04 30.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 124.131 0.972 . . . . 0.0 109.319 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 74.8 mt -112.92 131.63 63.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.76 106.78 17.25 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -93.56 140.5 16.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.381 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -80.52 -64.8 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -173.56 170.16 4.16 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 12.7 pt-20 -78.38 127.98 32.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.07 -31.65 3.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.914 0.388 . . . . 0.0 111.38 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 43.8 mt-10 -137.89 168.31 19.95 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.77 91.89 1.97 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.373 0.606 . . . . 0.0 110.545 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 116.73 -11.76 15.55 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.938 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 90.6 m95 -117.89 116.95 27.98 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.352 0.596 . . . . 0.0 110.402 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 40.1 m0 -105.58 155.33 19.31 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 t -118.79 139.73 51.1 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.07 -172.26 44.79 Favored Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.7 t -130.53 146.1 51.99 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.79 -62.28 1.59 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -176.11 22.81 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.514 1.526 . . . . 0.0 107.295 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -172.11 -67.73 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.317 -169.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.87 120.03 25.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.83 133.25 53.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.48 -153.19 8.32 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.969 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.5 mm? -111.43 144.8 40.05 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -150.41 145.21 18.25 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-N 118.23 0.468 . . . . 0.0 111.3 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 54.7 Cg_endo -73.9 130.47 14.52 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.05 1.833 . . . . 0.0 110.766 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -78.99 17.34 0.76 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -75.05 -46.72 32.97 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.748 0.785 . . . . 0.0 109.173 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 54.8 m-85 -87.33 -6.95 58.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.084 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.02 142.32 38.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.853 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -122.27 128.82 51.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.0 109.94 7.9 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.526 0.73 . . . . 0.0 109.927 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mp 62.0 -173.15 0.15 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.665 0.786 . . . . 0.0 111.957 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -100.17 -28.25 13.11 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 117.348 0.574 . . . . 0.0 109.872 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.7 tpt -125.03 139.21 54.01 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.061 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.95 102.83 1.83 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.513 ' HD3' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -77.07 126.63 31.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 90.4 mt-30 -123.82 170.05 10.95 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.53 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.7 p -144.27 135.26 25.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.391 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.43 148.33 24.86 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 O-C-N 124.156 0.91 . . . . 0.0 110.976 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.43 -47.77 6.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.25 146.46 45.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.434 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.44 138.97 39.56 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.154 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 19.2 t80 -113.48 -59.44 2.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.257 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t 64.0 100.69 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -170.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 44.5 Cg_endo -61.51 158.95 33.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.594 2.196 . . . . 0.0 112.781 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -92.91 -39.87 10.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -115.06 -173.58 2.34 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.828 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -85.18 -13.49 49.89 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.51 -43.18 63.93 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.582 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.9 mp0 -72.34 147.8 45.95 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.951 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.12 147.72 28.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -71.76 109.57 5.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.937 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 43.6 mt -102.67 110.76 22.8 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.038 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.93 134.42 62.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.81 127.14 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.609 0.719 . . . . 0.0 112.116 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.26 -4.32 70.33 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.257 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -95.99 169.77 9.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 117.882 0.841 . . . . 0.0 109.567 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.32 139.43 51.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.508 0.67 . . . . 0.0 111.121 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.4 138.22 46.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.127 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 11.2 t70 -94.3 93.18 7.58 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG13 ' HD3' ' A' ' 5' ' ' ARG . 7.7 p -77.85 115.15 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.71 0.767 . . . . 0.0 110.467 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 48' ' ' LEU . 50.6 mt -71.24 -57.97 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.796 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -178.37 7.22 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.577 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -129.29 117.78 21.22 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.153 0.502 . . . . 0.0 111.386 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.2 -24.02 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.94 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -133.68 170.01 16.19 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.497 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.27 -45.9 24.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -84.58 -28.01 33.86 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.499 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.405 ' CZ3' ' HD3' ' A' ' 52' ' ' PRO . 91.7 m95 -115.24 117.28 30.06 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.494 0.664 . . . . 0.0 111.618 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -105.69 150.73 25.21 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 104.02 13.23 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.885 0.85 . . . . 0.0 110.797 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 167.42 24.37 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.962 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 t -114.09 131.49 56.38 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.08 -63.66 1.22 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -119.05 -72.12 0.7 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -123.64 -14.43 7.29 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.417 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -84.21 115.8 22.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 HD12 ' A' ' 32' ' ' ILE . 64.6 tp -85.98 124.22 32.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.11 166.3 26.73 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 tp -97.72 138.18 35.48 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.29 149.9 33.19 Favored Pre-proline 0 C--N 1.295 -1.766 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.82 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 53.6 Cg_endo -71.34 122.01 8.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.715 2.277 . . . . 0.0 111.861 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 p -69.46 -10.64 58.9 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.774 0.83 . . . . 0.0 113.193 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.16 -15.48 60.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.737 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -101.99 7.01 41.47 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.363 -0.836 . . . . 0.0 112.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.67 167.22 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.88 145.97 48.77 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -85.55 144.64 27.79 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.238 0.542 . . . . 0.0 112.062 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.48 168.36 20.03 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.923 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.694 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.429 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -114.32 171.79 7.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.3 tpp -84.06 96.65 8.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.86 107.46 1.12 Allowed Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -88.75 -179.71 6.06 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 111.426 0.158 . . . . 0.0 111.426 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.463 ' O ' HD13 ' A' ' 59' ' ' LEU . 61.0 mt-30 -51.39 124.22 11.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 124.834 1.334 . . . . 0.0 108.676 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.7 p -83.24 131.44 35.1 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.031 -172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' O ' ' HD3' ' A' ' 57' ' ' LYS . 49.6 mttm -87.05 144.22 26.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.65 141.91 15.03 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' CD2' ' HD2' ' A' ' 57' ' ' LYS . 34.0 mt -99.94 -54.78 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 111.099 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -127.92 164.53 22.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.003 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.29 149.92 35.33 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.536 0.523 . . . . 0.0 110.856 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 79.8 t80 -146.75 113.43 6.03 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 26.5 t -103.84 108.0 58.4 Favored Pre-proline 0 N--CA 1.399 -3.021 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 29.2 Cg_endo -62.11 163.53 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.293 2.662 . . . . 0.0 112.732 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -92.87 -43.69 8.85 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -107.87 -173.14 2.21 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.14 15.64 25.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.24 0.543 . . . . 0.0 109.545 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.77 -36.77 13.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.371 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.3 mp0 -80.86 171.15 15.37 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 46.0 tp -106.24 139.81 40.17 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.4 164.17 26.79 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.573 0.701 . . . . 0.0 111.371 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 72.9 mt -133.27 124.39 27.24 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.28 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.44 123.78 68.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.09 116.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.453 0.644 . . . . 0.0 111.039 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.87 -8.96 29.71 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.398 -0.905 . . . . 0.0 112.966 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.33 177.88 5.81 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.15 134.38 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.515 0.726 . . . . 0.0 109.061 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -113.08 134.39 55.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.5 94.55 4.97 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.93 104.24 7.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.843 0.83 . . . . 0.0 109.136 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 33' ' ' GLU . 65.2 mt -81.49 -58.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.186 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 32' ' ' ILE . 20.8 mm-40 -138.55 169.27 18.1 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.457 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -115.96 137.51 52.05 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.68 -26.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.288 0.566 . . . . 0.0 110.489 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -138.07 178.15 7.34 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -84.91 -17.22 38.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.01 -1.36 20.82 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.523 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -136.13 124.63 23.54 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.018 0.437 . . . . 0.0 110.879 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 52.5 m0 -113.86 158.24 21.31 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.224 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -103.99 111.22 23.68 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.19 165.07 28.98 Favored Glycine 0 N--CA 1.424 -2.161 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.756 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 4.9 t -110.17 129.44 55.71 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -90.85 -74.74 0.49 Allowed 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.9 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.52 -21.68 12.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.245 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -165.9 -42.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.078 0.466 . . . . 0.0 110.441 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.8 mptm? -94.47 140.55 29.68 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.9 tp -90.43 101.36 14.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.801 -1.545 . . . . 0.0 106.948 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.17 177.29 18.59 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.794 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.6 mp -92.24 128.0 37.93 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.7 p90 -126.47 145.88 54.57 Favored Pre-proline 0 C--N 1.288 -2.082 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.687 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.48 113.11 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.614 2.209 . . . . 0.0 111.728 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.94 -24.44 62.53 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.875 1.27 . . . . 0.0 113.265 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.89 -22.33 64.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -99.39 16.19 23.91 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.818 -0.551 . . . . 0.0 111.959 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.49 162.15 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -119.42 126.2 50.78 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.161 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.01 133.25 40.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.88 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 6' ' ' GLN . 7.3 mp -96.88 129.89 44.25 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.566 0.222 . . . . 0.0 110.748 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 173.244 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.977 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m -81.26 91.61 6.23 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.264 0.554 . . . . 0.0 109.71 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp -92.87 -29.75 15.77 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.065 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.45 139.78 5.08 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.487 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -103.0 167.62 9.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.441 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.5 pt20 -50.29 135.83 20.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.891 0.853 . . . . 0.0 111.929 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.0 p -121.63 140.48 52.21 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.861 -172.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -93.61 154.39 17.87 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 56' ' ' VAL . 48.6 t -82.12 129.87 36.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.527 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -96.14 -49.07 5.39 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.499 . . . . 0.0 109.848 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -130.8 147.88 52.51 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.63 135.41 45.49 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.499 0.5 . . . . 0.0 110.554 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 40.4 t80 -114.92 109.46 18.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -91.18 105.7 13.47 Favored Pre-proline 0 N--CA 1.403 -2.821 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 34.3 Cg_endo -68.47 163.2 37.58 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.055 2.503 . . . . 0.0 114.021 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.96 -33.1 39.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.205 1.002 . . . . 0.0 109.004 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -125.34 -168.5 1.84 Allowed 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -104.75 18.37 22.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.53 -47.01 13.65 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.149 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.7 mp0 -68.09 159.14 31.51 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 tp -80.87 125.72 30.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.58 122.77 20.36 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 122.015 0.912 . . . . 0.0 112.016 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 47.0 mt -96.26 108.74 21.27 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.866 -1.515 . . . . 0.0 109.018 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 125.9 66.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.87 136.29 26.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.27 0.557 . . . . 0.0 110.558 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.02 -22.95 15.03 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.661 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.85 172.5 7.4 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.457 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.4 129.14 64.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 124.509 1.123 . . . . 0.0 108.802 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.51 132.65 60.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.11 105.67 17.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 12.8 p -86.71 148.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.209 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.1 -55.43 6.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.83 -176.32 1.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.18 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 11.9 pt-20 -107.39 141.66 38.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -96.46 -25.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.058 0.456 . . . . 0.0 110.779 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.33 151.98 38.38 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.86 94.23 0.82 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.648 0.737 . . . . 0.0 109.246 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 137.01 -23.13 3.22 Favored Glycine 0 N--CA 1.415 -2.713 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.905 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -124.75 114.8 19.76 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.609 0.719 . . . . 0.0 112.093 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 21.7 m0 -99.28 142.96 30.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.231 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -105.24 106.56 17.12 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 31' ' ' VAL . . . -145.98 167.73 27.72 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.28 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -111.79 131.23 55.47 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.656 0.741 . . . . 0.0 110.644 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.75 -34.51 69.55 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.246 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -164.27 -68.61 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.749 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.14 -16.23 6.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.03 110.23 20.46 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -89.55 131.22 35.68 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.6 174.92 35.73 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.339 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.14 136.36 37.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -142.64 145.14 32.97 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 56.2 Cg_endo -72.14 129.8 15.62 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 122.06 1.84 . . . . 0.0 112.17 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 5.6 p -79.24 15.34 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p-10 -95.1 -15.34 23.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.04 0.447 . . . . 0.0 109.887 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.22 6.74 28.92 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.051 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 9' ' ' VAL . 27.1 m -142.69 144.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 58' ' ' GLU . 11.4 ptmt -100.75 -107.64 0.22 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.294 172.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' LYS . 40.5 tt0 -171.03 145.85 2.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 6' ' ' GLN . 4.5 pp -99.78 166.68 10.97 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.318 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.283 -2.283 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.951 -174.73 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.2 t -103.41 -43.21 5.48 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 117.414 0.607 . . . . 0.0 109.475 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 tpt -148.87 162.57 39.57 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.52 -35.78 92.26 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 73.73 168.98 0.31 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.866 1.666 . . . . 0.0 112.894 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.605 ' HB2' HD21 ' A' ' 59' ' ' LEU . 45.4 mt-30 -137.33 -176.5 4.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 9.5 p -148.01 137.34 22.22 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.952 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HB2' ' HD3' ' A' ' 57' ' ' LYS . 3.5 mptp? -83.14 149.27 26.97 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 23' ' ' LEU . 61.0 t -97.08 121.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.995 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.77 -47.04 7.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.0 110.897 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.82 146.53 45.62 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.54 162.22 22.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.067 0.461 . . . . 0.0 110.906 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -146.03 127.11 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.262 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 t -104.78 106.32 54.46 Favored Pre-proline 0 N--CA 1.416 -2.145 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 37.1 Cg_endo -68.86 171.72 12.98 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 123.433 2.755 . . . . 0.0 114.445 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -86.71 -48.23 8.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.3 -177.83 3.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.969 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -85.86 -6.28 59.11 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.695 0.283 . . . . 0.0 110.393 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.14 -32.84 71.02 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.6 mp0 -77.22 173.06 12.31 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.27 130.33 55.97 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.42 156.95 38.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' HG11 ' A' ' 9' ' ' VAL . 51.9 mt -120.79 112.41 18.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.89 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mm -94.31 122.16 45.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.65 126.01 20.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.383 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 -15.44 63.34 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.054 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.26 -172.46 3.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.173 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.59 136.4 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 121.633 0.73 . . . . 0.0 111.672 -174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 75.0 mt -110.28 134.6 51.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.876 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.56 120.47 43.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.0 mt -88.14 -49.21 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -170.69 147.14 2.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.3 pt-20 -90.07 106.71 18.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.19 -40.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.038 -174.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 61.5 mm-40 -122.52 168.05 12.62 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.89 110.96 9.62 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 106.24 -26.7 19.53 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.264 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 95.5 m95 -108.56 114.48 28.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.413 0.625 . . . . 0.0 110.986 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 44.3 m0 -99.09 145.57 27.0 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.965 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -105.32 113.75 27.52 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.1 -177.62 27.7 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.296 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -133.14 129.37 37.79 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.5 tp -84.31 -65.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -104.05 -72.82 0.69 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -137.13 -5.44 1.87 Allowed 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.576 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -99.77 121.42 41.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.62 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 tt -77.64 128.17 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 169.5 32.85 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.81 132.76 36.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -139.87 144.92 40.47 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 58.1 Cg_endo -74.87 125.99 9.76 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.071 1.847 . . . . 0.0 111.851 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 56' ' ' VAL . 15.9 p -60.45 -22.61 63.65 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.465 1.106 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -58.27 -27.1 63.71 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.928 0.891 . . . . 0.0 112.4 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.63 -2.93 40.45 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.851 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 53' ' ' SER . 34.1 m -113.48 158.02 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 8' ' ' LYS . 19.0 ptmt -101.86 -11.6 18.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.143 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.74 174.02 0.27 Allowed 'General case' 0 CA--C 1.561 1.37 0 O-C-N 124.117 0.886 . . . . 0.0 108.779 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' A' ' 6' ' ' GLN . 3.6 pp -143.39 177.65 8.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.406 -0.809 . . . . 0.0 110.338 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--N 1.293 -1.86 0 O-C-N 123.763 0.664 . . . . 0.0 109.5 -174.606 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -102.34 -10.24 19.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.864 0.332 . . . . 0.0 111.753 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 69.64 -74.45 0.08 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.793 1.237 . . . . 0.0 113.016 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.04 -165.44 12.02 Favored Glycine 0 C--N 1.296 -1.641 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -140.87 124.2 16.67 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 80.5 mt-30 -130.88 136.59 48.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.02 0.438 . . . . 0.0 110.779 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 26.7 p -114.92 152.54 32.12 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.828 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -107.6 149.8 27.62 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.764 0.316 . . . . 0.0 110.338 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 41.8 t -91.4 113.38 26.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.225 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.471 HD12 ' HD3' ' A' ' 57' ' ' LYS . 57.7 mt -107.0 -38.92 5.9 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.887 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -107.57 159.47 16.42 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.77 148.6 24.23 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.5 t80 -114.57 -67.96 0.96 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.8 t 67.44 101.95 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -169.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.11 161.61 36.44 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.757 2.305 . . . . 0.0 113.321 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -87.29 -38.19 16.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.57 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 21.1 m120 -119.18 -175.45 2.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.865 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.82 -3.28 49.25 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.435 0.636 . . . . 0.0 109.577 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.56 -52.93 21.71 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.902 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.57 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -60.6 164.05 4.9 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.836 0.826 . . . . 0.0 111.615 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.4 tp -90.7 132.26 35.9 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.6 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.77 158.32 36.52 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-O 121.586 0.707 . . . . 0.0 110.078 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 13' ' ' TYR . 46.6 mt -123.98 101.21 7.12 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.229 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.11 120.43 38.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.1 t -63.67 124.66 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.864 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.03 -12.21 55.89 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.913 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.99 155.06 19.72 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.088 0.47 . . . . 0.0 111.889 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.31 135.78 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.53 119.55 60.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 29.4 t70 -82.53 117.16 22.33 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.96 143.9 15.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -88.8 -57.26 4.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.76 164.2 21.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -92.11 120.65 32.92 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.02 -29.23 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.635 0.731 . . . . 0.0 109.085 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 21.9 mm-40 -130.81 157.82 41.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -77.23 -26.85 53.05 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.727 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -90.06 -37.6 6.7 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.694 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -110.02 109.82 20.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.21 0.529 . . . . 0.0 110.772 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.0 m0 -94.35 163.98 13.2 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.225 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -115.37 114.29 24.91 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.088 0.471 . . . . 0.0 110.637 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.94 177.47 34.66 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -125.12 144.09 50.6 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.936 0.368 . . . . 0.0 110.108 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.38 -68.24 0.8 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -122.7 -49.5 2.0 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.05 -37.13 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.758 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.82 118.51 28.57 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.675 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -91.92 119.17 31.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.07 14.64 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.33 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.4 mp -100.24 146.18 27.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.764 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.09 147.03 22.52 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.545 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 51.4 Cg_endo -75.01 129.3 12.21 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.988 1.792 . . . . 0.0 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 p -75.52 21.09 0.15 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.404 1.082 . . . . 0.0 112.958 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -87.65 -44.06 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.388 0.613 . . . . 0.0 110.008 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.3 -7.53 56.6 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.265 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 9' ' ' VAL . 30.4 m -123.21 146.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.317 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' A' ' 10' ' ' LEU . 4.0 mptp? -127.38 144.93 50.98 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 173.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 30.0 tt0 -90.0 109.12 20.17 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.91 123.31 33.15 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.854 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.488 -178.278 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.19 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 t -80.51 95.78 6.59 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.4 mtp -99.62 107.39 19.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 111.019 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.35 -95.56 0.25 Allowed Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.501 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 60.94 3.89 0.72 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.127 1.371 . . . . 0.0 113.422 -176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.0 167.85 12.09 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.37 128.83 54.44 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -83.94 147.31 27.55 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.668 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.5 t -90.56 133.72 31.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HD3' ' A' ' 57' ' ' LYS . 62.1 mt -95.1 -58.6 2.1 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.758 0.823 . . . . 0.0 109.526 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.12 160.18 24.24 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.088 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.4 158.58 24.58 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.166 0.508 . . . . 0.0 110.156 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.3 -58.3 2.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t 71.4 105.4 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.537 1.135 . . . . 0.0 109.105 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.23 154.86 43.45 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.279 1.986 . . . . 0.0 111.448 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -83.74 -29.46 27.45 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.475 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 89.2 m-20 -112.13 -80.37 0.59 Allowed 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.504 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 167.6 -24.96 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.296 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.68 -21.72 61.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -74.7 150.98 39.28 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.12 117.65 20.35 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.973 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.18 126.75 28.72 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.342 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 51' ' ' PHE . 38.7 mt -91.9 117.02 29.4 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.47 114.11 28.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.228 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.76 127.08 26.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.348 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.97 -9.86 75.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.458 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.66 178.99 4.4 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.32 129.39 73.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.775 0.321 . . . . 0.0 110.926 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.86 141.08 15.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 123.535 0.734 . . . . 0.0 110.696 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.72 95.72 9.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.93 144.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.579 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.8 mt -113.74 -54.78 4.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.91 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -155.65 160.99 40.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 8.6 pt-20 -100.91 142.92 31.7 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 m -100.35 -25.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 44.7 mt-10 -139.11 164.82 28.78 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.03 -39.14 91.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 123.548 0.53 . . . . 0.0 110.16 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.83 -40.19 5.98 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.039 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -92.14 105.87 18.01 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.768 0.794 . . . . 0.0 111.638 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 43.6 m0 -93.74 153.49 18.3 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.014 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -109.7 120.5 42.69 Favored 'General case' 0 C--O 1.261 1.705 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.2 177.93 36.45 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -134.55 166.46 22.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.56 -60.53 0.79 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.36 0.6 . . . . 0.0 109.617 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -114.27 -69.74 0.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -128.22 -29.31 2.51 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.993 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -85.82 121.81 28.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.074 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 tp -98.93 107.01 19.33 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.75 -169.53 18.11 Favored Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 112.653 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 71.7 mt -96.93 146.22 25.16 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.837 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 23' ' ' LEU . 44.1 p90 -147.42 147.5 28.38 Favored Pre-proline 0 C--N 1.299 -1.614 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.736 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.81 123.23 7.83 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.362 2.041 . . . . 0.0 111.701 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 56' ' ' VAL . 32.9 t -71.51 -10.96 60.57 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.24 -21.66 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.639 -0.663 . . . . 0.0 112.35 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.69 10.39 41.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.813 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 53' ' ' SER . 21.7 m -133.4 155.87 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.723 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' A' ' 10' ' ' LEU . 4.3 mptp? -122.45 126.43 47.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.554 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.05 24.99 0.73 Allowed 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.416 1.086 . . . . 0.0 111.89 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.09 133.51 49.75 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.981 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.286 -2.157 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.473 -179.737 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.828 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -156.8 -171.01 3.5 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ptm -74.76 84.52 2.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.342 1.068 . . . . 0.0 110.528 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.14 128.19 2.1 Favored Glycine 0 N--CA 1.403 -3.552 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -78.03 120.91 23.53 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -68.03 140.01 56.31 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.627 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.89 149.04 24.61 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.328 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -98.64 143.01 29.49 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.397 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 56' ' ' VAL . 21.6 t -84.97 108.03 16.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.957 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.36 -34.6 17.55 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.861 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.27 150.28 50.99 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.467 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -80.49 158.43 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.142 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -150.16 110.06 4.1 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.751 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -97.95 107.55 41.22 Favored Pre-proline 0 N--CA 1.411 -2.377 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 63.4 Cg_exo -48.33 154.67 2.44 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 124.543 3.495 . . . . 0.0 114.457 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.13 -21.86 25.71 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.252 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 91.2 m-20 -130.95 -161.72 1.15 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -105.18 7.05 33.52 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.527 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.49 -43.26 40.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.824 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.16 159.16 30.96 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.574 0.702 . . . . 0.0 111.041 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.61 143.78 28.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 20.3 mt-10 -81.91 120.57 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.1 mt -97.72 120.47 38.16 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.138 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.83 122.59 69.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.24 130.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 123.98 0.912 . . . . 0.0 112.827 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.25 -3.62 64.19 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.528 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.2 -178.48 3.67 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.18 138.74 53.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.694 0.798 . . . . 0.0 108.984 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.54 134.11 52.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.626 0.251 . . . . 0.0 110.452 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.65 96.7 4.9 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.51 129.54 36.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.256 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.7 mt -98.59 -61.35 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.5 176.81 6.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.7 pt-20 -108.32 128.3 54.62 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.983 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.97 -35.54 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.58 170.0 16.72 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.255 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.42 93.95 3.02 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.38 -35.79 3.1 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -99.84 114.18 27.19 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.334 0.588 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.9 m0 -99.66 158.37 15.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -111.99 120.38 41.69 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.23 33.85 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.536 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.9 m -105.92 128.37 53.74 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -81.25 -60.17 2.38 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -140.22 -65.72 0.45 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.033 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.83 -17.21 12.1 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.513 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -120.67 142.45 49.46 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.262 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 49' ' ' GLY . 5.7 tt -94.35 135.75 35.42 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 48' ' ' LEU . . . -150.45 170.2 30.36 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.068 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 69.5 mt -101.39 131.08 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -139.81 146.14 45.9 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.236 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.74 133.24 8.01 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.142 1.895 . . . . 0.0 111.366 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -80.44 42.58 0.6 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.781 0.801 . . . . 0.0 111.348 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -102.22 -40.56 6.72 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.22 -9.42 45.35 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 9' ' ' VAL . 35.9 m -127.01 140.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.734 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -124.6 142.08 51.62 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.628 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -84.15 99.69 10.67 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.88 153.77 48.32 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--N 1.29 -2.022 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.647 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.567 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -65.95 -54.68 23.14 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.178 0.591 . . . . 0.0 110.867 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.0 tpt -106.51 147.45 29.38 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.5 57.02 2.68 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 106.469 -2.652 . . . . 0.0 106.469 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER -57.85 135.93 56.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.653 -1.274 . . . . 0.0 108.079 -177.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 51.2 mt-30 -87.69 152.46 22.13 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.983 -172.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.7 p -120.74 155.94 32.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.258 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.6 mttm -105.72 140.13 39.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.572 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 23' ' ' LEU . 99.8 t -78.79 118.79 26.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.139 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -101.82 -34.38 9.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.809 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -124.52 154.39 40.63 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.81 154.02 28.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -113.58 -52.46 2.75 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.624 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m 58.67 88.35 0.12 Allowed Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 110.487 -173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.19 153.46 39.39 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.05 2.5 . . . . 0.0 113.173 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -90.62 -17.68 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.73 -167.08 1.92 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -105.29 5.91 32.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.66 -31.18 16.72 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.225 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 2.8 mp0 -74.85 178.67 5.36 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.382 0.61 . . . . 0.0 110.134 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.7 tp -94.73 136.25 35.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -84.49 117.06 23.44 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.976 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 9' ' ' VAL . 26.7 mt -89.96 108.42 19.71 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.696 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.22 127.62 41.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.7 p -68.54 128.14 31.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 CA-C-O 121.803 0.811 . . . . 0.0 112.253 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.67 87.59 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.882 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 3.7 t0 -87.25 169.24 12.49 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.476 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.7 t -114.27 129.36 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.322 0.649 . . . . 0.0 110.709 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.31 134.83 53.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 122.972 0.509 . . . . 0.0 110.863 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 33.5 t70 -86.69 105.19 16.76 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 t -84.85 121.29 36.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.101 -176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -90.09 -50.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.76 152.86 18.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.158 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.9 pt-20 -90.1 124.43 34.8 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 168.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.49 -34.99 7.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.818 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -138.29 153.51 49.04 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -71.54 112.61 7.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.225 0.536 . . . . 0.0 109.856 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 110.32 -13.02 30.95 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.423 -177.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -126.7 107.02 9.79 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.38 0.609 . . . . 0.0 110.876 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.3 m0 -94.54 143.53 26.34 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -107.56 114.8 29.04 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.03 170.79 34.37 Favored Glycine 0 N--CA 1.42 -2.404 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -118.5 141.82 48.19 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.84 -54.92 4.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -132.54 -59.99 0.9 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.117 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.06 -21.6 2.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -101.91 115.64 30.98 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.955 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.97 108.54 5.94 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.83 173.2 16.56 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.954 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 18.1 tp -107.35 139.75 41.34 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -150.64 147.58 21.61 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 121.365 -0.134 . . . . 0.0 110.984 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 41.0 Cg_endo -71.3 129.45 15.99 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.089 1.859 . . . . 0.0 111.3 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -68.02 -22.29 64.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.7 0.8 . . . . 0.0 112.844 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -57.32 -33.06 67.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.964 0.506 . . . . 0.0 112.36 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -90.48 -6.66 54.57 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 27.3 m -118.48 137.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.229 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 13.5 mptt -116.19 131.87 56.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.802 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.21 116.13 20.94 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.995 -174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 59' ' ' LEU . 1.8 pt? -78.84 126.94 31.39 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 7.1 pt-20 . . . . . 0 C--N 1.28 -2.425 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.99 -170.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 121.321 0.581 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.9 p -110.01 131.28 55.2 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.118 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 50.2 tttp -91.68 148.25 22.4 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 56' ' ' VAL . 43.1 t -88.22 114.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.02 -34.26 9.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 123.802 0.689 . . . . 0.0 111.513 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -121.79 160.68 24.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.271 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.71 131.18 35.26 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.601 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -131.46 113.01 13.19 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.214 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 31.6 m -94.1 106.75 24.18 Favored Pre-proline 0 N--CA 1.403 -2.783 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 37.1 Cg_endo -64.01 149.89 89.54 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.309 2.673 . . . . 0.0 113.836 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 16' ' ' GLN . 12.9 mt-30 -88.45 -30.04 19.73 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.357 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 38.0 m-80 -130.0 156.61 44.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.88 -7.39 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.942 0.877 . . . . 0.0 110.63 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.74 -21.72 60.12 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 63.3 mt-10 -84.24 126.02 32.76 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.26 132.1 44.44 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.397 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.25 114.32 7.39 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 122.164 0.983 . . . . 0.0 111.791 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 mt -87.0 104.79 16.64 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.322 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.67 120.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.613 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.93 121.04 12.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 -28.61 7.93 Favored Glycine 0 N--CA 1.427 -1.922 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.332 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.3 175.59 8.82 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.765 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 14.1 p -124.14 137.72 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.6 mt -109.28 130.71 61.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 121.136 0.493 . . . . 0.0 109.957 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.1 107.25 17.75 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.8 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.117 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.39 -59.64 2.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -164.22 157.67 18.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.5 139.59 30.54 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -106.48 -44.21 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.5 70.01 1.38 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.574 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 52.33 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.959 1.704 . . . . 0.0 113.585 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -71.5 -42.84 54.85 Favored Glycine 0 N--CA 1.419 -2.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.362 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -89.31 111.93 22.88 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.81 0.814 . . . . 0.0 111.949 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -101.2 164.27 11.87 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.788 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 m -124.78 120.62 32.28 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.946 0.403 . . . . 0.0 110.288 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.79 178.33 36.82 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -129.15 138.68 51.92 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.336 0.589 . . . . 0.0 110.827 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -111.01 101.03 9.62 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 68.39 -78.93 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.483 1.113 . . . . 0.0 113.068 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -131.14 -6.79 3.87 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -107.02 125.54 51.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.218 0.533 . . . . 0.0 110.923 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.18 136.53 37.56 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.28 -179.05 39.96 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 118.903 -1.618 . . . . 0.0 113.28 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 72.6 mt -99.17 137.71 37.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.63 141.54 22.96 Favored Pre-proline 0 C--N 1.291 -1.974 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.166 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 61.1 Cg_endo -78.71 128.88 8.86 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.378 2.052 . . . . 0.0 112.552 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 p -72.81 21.6 0.07 Allowed 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.152 1.381 . . . . 0.0 113.271 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.54 -42.71 10.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -90.27 -12.04 39.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.702 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 9' ' ' VAL . 32.6 m -121.6 140.07 46.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.976 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -121.39 141.71 50.71 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.744 0.307 . . . . 0.0 110.92 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--N 1.308 -1.222 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.775 0 CA-C-O 121.333 0.587 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 25.7 p -111.48 152.39 27.5 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.971 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -100.49 144.9 28.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.69 109.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.56 -38.91 11.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 90.4 m-85 -127.75 156.24 42.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -99.34 162.44 13.04 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.843 -175.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 15' ' ' PRO . 41.3 t80 -137.38 124.05 21.06 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 22.9 t -91.53 105.6 13.64 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 18.4 Cg_endo -60.78 141.2 94.18 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.198 2.599 . . . . 0.0 112.671 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.2 -36.79 69.28 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.01 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 16.2 m-80 -129.39 161.87 29.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.97 4.36 19.81 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.68 -19.43 45.2 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.4 mp0 -86.03 139.26 31.32 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.037 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -75.16 129.67 37.92 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.0 109.01 2.81 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 122.22 1.009 . . . . 0.0 110.56 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 43.3 mt -84.34 112.96 20.8 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 113.726 -1.579 . . . . 0.0 108.494 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -111.64 126.55 69.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 12' ' ' ASP . 43.4 t -61.09 128.33 22.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 O-C-N 123.428 0.455 . . . . 0.0 111.183 -176.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.71 -39.25 2.8 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.259 -0.972 . . . . 0.0 114.128 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -86.36 176.31 7.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.895 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.3 141.04 30.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 124.131 0.972 . . . . 0.0 109.319 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 74.8 mt -112.92 131.63 63.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.76 106.78 17.25 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -93.56 140.5 16.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.381 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -80.52 -64.8 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -173.56 170.16 4.16 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 12.7 pt-20 -78.38 127.98 32.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.07 -31.65 3.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.914 0.388 . . . . 0.0 111.38 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 43.8 mt-10 -137.89 168.31 19.95 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.77 91.89 1.97 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.373 0.606 . . . . 0.0 110.545 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 116.73 -11.76 15.55 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.938 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 90.6 m95 -117.89 116.95 27.98 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.352 0.596 . . . . 0.0 110.402 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 40.1 m0 -105.58 155.33 19.31 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 t -118.79 139.73 51.1 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.07 -172.26 44.79 Favored Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.7 t -130.53 146.1 51.99 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.79 -62.28 1.59 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -176.11 22.81 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.514 1.526 . . . . 0.0 107.295 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -172.11 -67.73 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.317 -169.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.87 120.03 25.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.83 133.25 53.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.48 -153.19 8.32 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.969 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.5 mm? -111.43 144.8 40.05 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -150.41 145.21 18.25 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-N 118.23 0.468 . . . . 0.0 111.3 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 54.7 Cg_endo -73.9 130.47 14.52 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.05 1.833 . . . . 0.0 110.766 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -78.99 17.34 0.76 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -75.05 -46.72 32.97 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.748 0.785 . . . . 0.0 109.173 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 54.8 m-85 -87.33 -6.95 58.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.084 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.02 142.32 38.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.853 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -122.27 128.82 51.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 123.526 0.73 . . . . 0.0 109.927 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 90.4 mt-30 . . . . . 0 CA--C 1.506 -0.744 0 CA-C-O 120.582 0.229 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.7 p -144.27 135.26 25.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.391 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.43 148.33 24.86 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 O-C-N 124.156 0.91 . . . . 0.0 110.976 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.43 -47.77 6.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.25 146.46 45.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.434 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.44 138.97 39.56 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.154 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 19.2 t80 -113.48 -59.44 2.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.257 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t 64.0 100.69 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -170.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 44.5 Cg_endo -61.51 158.95 33.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.594 2.196 . . . . 0.0 112.781 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -92.91 -39.87 10.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -115.06 -173.58 2.34 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.828 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -85.18 -13.49 49.89 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.51 -43.18 63.93 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.582 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.9 mp0 -72.34 147.8 45.95 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.951 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.12 147.72 28.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -71.76 109.57 5.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.937 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 43.6 mt -102.67 110.76 22.8 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.038 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.93 134.42 62.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.81 127.14 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.609 0.719 . . . . 0.0 112.116 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.26 -4.32 70.33 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.257 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -95.99 169.77 9.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 117.882 0.841 . . . . 0.0 109.567 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.32 139.43 51.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.508 0.67 . . . . 0.0 111.121 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.4 138.22 46.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.127 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 11.2 t70 -94.3 93.18 7.58 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.85 115.15 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.71 0.767 . . . . 0.0 110.467 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 48' ' ' LEU . 50.6 mt -71.24 -57.97 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.796 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -178.37 7.22 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.577 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -129.29 117.78 21.22 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.153 0.502 . . . . 0.0 111.386 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.2 -24.02 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.94 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -133.68 170.01 16.19 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.497 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.27 -45.9 24.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -84.58 -28.01 33.86 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.499 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.405 ' CZ3' ' HD3' ' A' ' 52' ' ' PRO . 91.7 m95 -115.24 117.28 30.06 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.494 0.664 . . . . 0.0 111.618 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -105.69 150.73 25.21 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 104.02 13.23 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.885 0.85 . . . . 0.0 110.797 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 167.42 24.37 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.962 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 t -114.09 131.49 56.38 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.08 -63.66 1.22 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.05 -72.12 0.7 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -123.64 -14.43 7.29 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.417 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -84.21 115.8 22.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 HD12 ' A' ' 32' ' ' ILE . 64.6 tp -85.98 124.22 32.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.11 166.3 26.73 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 tp -97.72 138.18 35.48 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.29 149.9 33.19 Favored Pre-proline 0 C--N 1.295 -1.766 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.82 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 53.6 Cg_endo -71.34 122.01 8.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.715 2.277 . . . . 0.0 111.861 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 p -69.46 -10.64 58.9 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.774 0.83 . . . . 0.0 113.193 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.16 -15.48 60.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.737 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -101.99 7.01 41.47 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.363 -0.836 . . . . 0.0 112.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.67 167.22 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.88 145.97 48.77 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 . . . . . 0 C--N 1.295 -1.791 0 CA-C-O 121.238 0.542 . . . . 0.0 112.062 -175.431 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 6' ' ' GLN . 9.6 mt-30 . . . . . 0 C--O 1.241 0.623 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.7 p -83.24 131.44 35.1 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.031 -172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.42 ' O ' ' HD3' ' A' ' 57' ' ' LYS . 49.6 mttm -87.05 144.22 26.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.65 141.91 15.03 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' CD2' ' HD2' ' A' ' 57' ' ' LYS . 34.0 mt -99.94 -54.78 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 111.099 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -127.92 164.53 22.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.003 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.29 149.92 35.33 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.536 0.523 . . . . 0.0 110.856 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 79.8 t80 -146.75 113.43 6.03 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 26.5 t -103.84 108.0 58.4 Favored Pre-proline 0 N--CA 1.399 -3.021 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 29.2 Cg_endo -62.11 163.53 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.293 2.662 . . . . 0.0 112.732 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -92.87 -43.69 8.85 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -107.87 -173.14 2.21 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.14 15.64 25.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.24 0.543 . . . . 0.0 109.545 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.77 -36.77 13.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.371 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.3 mp0 -80.86 171.15 15.37 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 46.0 tp -106.24 139.81 40.17 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.4 164.17 26.79 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.573 0.701 . . . . 0.0 111.371 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 72.9 mt -133.27 124.39 27.24 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.28 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.44 123.78 68.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.09 116.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.453 0.644 . . . . 0.0 111.039 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.87 -8.96 29.71 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.398 -0.905 . . . . 0.0 112.966 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.33 177.88 5.81 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.15 134.38 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.515 0.726 . . . . 0.0 109.061 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -113.08 134.39 55.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.5 94.55 4.97 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.93 104.24 7.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.843 0.83 . . . . 0.0 109.136 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 33' ' ' GLU . 65.2 mt -81.49 -58.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.186 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 32' ' ' ILE . 20.8 mm-40 -138.55 169.27 18.1 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.457 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -115.96 137.51 52.05 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.68 -26.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.288 0.566 . . . . 0.0 110.489 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -138.07 178.15 7.34 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -84.91 -17.22 38.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.01 -1.36 20.82 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.523 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -136.13 124.63 23.54 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.018 0.437 . . . . 0.0 110.879 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 52.5 m0 -113.86 158.24 21.31 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.224 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -103.99 111.22 23.68 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.19 165.07 28.98 Favored Glycine 0 N--CA 1.424 -2.161 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.756 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 4.9 t -110.17 129.44 55.71 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -90.85 -74.74 0.49 Allowed 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.9 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.52 -21.68 12.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.245 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -165.9 -42.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.078 0.466 . . . . 0.0 110.441 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.8 mptm? -94.47 140.55 29.68 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.9 tp -90.43 101.36 14.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.801 -1.545 . . . . 0.0 106.948 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.17 177.29 18.59 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.794 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.6 mp -92.24 128.0 37.93 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.7 p90 -126.47 145.88 54.57 Favored Pre-proline 0 C--N 1.288 -2.082 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.687 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.48 113.11 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.614 2.209 . . . . 0.0 111.728 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.94 -24.44 62.53 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.875 1.27 . . . . 0.0 113.265 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.89 -22.33 64.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -99.39 16.19 23.91 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.818 -0.551 . . . . 0.0 111.959 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.49 162.15 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -119.42 126.2 50.78 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.161 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.88 178.757 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.243 0.725 0 CA-C-O 121.891 0.853 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.0 p -121.63 140.48 52.21 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.861 -172.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -93.61 154.39 17.87 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 56' ' ' VAL . 48.6 t -82.12 129.87 36.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.527 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -96.14 -49.07 5.39 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.499 . . . . 0.0 109.848 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -130.8 147.88 52.51 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.63 135.41 45.49 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.499 0.5 . . . . 0.0 110.554 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 40.4 t80 -114.92 109.46 18.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -91.18 105.7 13.47 Favored Pre-proline 0 N--CA 1.403 -2.821 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 34.3 Cg_endo -68.47 163.2 37.58 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.055 2.503 . . . . 0.0 114.021 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.96 -33.1 39.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.205 1.002 . . . . 0.0 109.004 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -125.34 -168.5 1.84 Allowed 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -104.75 18.37 22.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.53 -47.01 13.65 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.149 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.7 mp0 -68.09 159.14 31.51 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 tp -80.87 125.72 30.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.58 122.77 20.36 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 122.015 0.912 . . . . 0.0 112.016 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 47.0 mt -96.26 108.74 21.27 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.866 -1.515 . . . . 0.0 109.018 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 125.9 66.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.87 136.29 26.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.27 0.557 . . . . 0.0 110.558 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.02 -22.95 15.03 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.661 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.85 172.5 7.4 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.457 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.4 129.14 64.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 124.509 1.123 . . . . 0.0 108.802 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.51 132.65 60.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.11 105.67 17.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 12.8 p -86.71 148.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.209 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.1 -55.43 6.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.83 -176.32 1.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.18 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 11.9 pt-20 -107.39 141.66 38.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -96.46 -25.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.058 0.456 . . . . 0.0 110.779 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.33 151.98 38.38 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.86 94.23 0.82 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.648 0.737 . . . . 0.0 109.246 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 137.01 -23.13 3.22 Favored Glycine 0 N--CA 1.415 -2.713 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.905 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -124.75 114.8 19.76 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.609 0.719 . . . . 0.0 112.093 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 21.7 m0 -99.28 142.96 30.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.231 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -105.24 106.56 17.12 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 31' ' ' VAL . . . -145.98 167.73 27.72 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.28 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -111.79 131.23 55.47 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.656 0.741 . . . . 0.0 110.644 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.75 -34.51 69.55 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.246 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -164.27 -68.61 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.749 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.14 -16.23 6.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.03 110.23 20.46 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -89.55 131.22 35.68 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.6 174.92 35.73 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.339 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.14 136.36 37.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -142.64 145.14 32.97 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 56.2 Cg_endo -72.14 129.8 15.62 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 122.06 1.84 . . . . 0.0 112.17 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 5.6 p -79.24 15.34 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p-10 -95.1 -15.34 23.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.04 0.447 . . . . 0.0 109.887 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.22 6.74 28.92 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.051 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 9' ' ' VAL . 27.1 m -142.69 144.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 58' ' ' GLU . 11.4 ptmt -100.75 -107.64 0.22 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.294 172.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' LYS . 40.5 tt0 . . . . . 0 C--N 1.296 -1.751 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 9.5 p -148.01 137.34 22.22 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.952 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HB2' ' HD3' ' A' ' 57' ' ' LYS . 3.5 mptp? -83.14 149.27 26.97 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 23' ' ' LEU . 61.0 t -97.08 121.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.995 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.77 -47.04 7.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.0 110.897 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.82 146.53 45.62 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.54 162.22 22.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.067 0.461 . . . . 0.0 110.906 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -146.03 127.11 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.262 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 t -104.78 106.32 54.46 Favored Pre-proline 0 N--CA 1.416 -2.145 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 37.1 Cg_endo -68.86 171.72 12.98 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 123.433 2.755 . . . . 0.0 114.445 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -86.71 -48.23 8.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.3 -177.83 3.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.969 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -85.86 -6.28 59.11 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.695 0.283 . . . . 0.0 110.393 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.14 -32.84 71.02 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.6 mp0 -77.22 173.06 12.31 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.27 130.33 55.97 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.42 156.95 38.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' HG11 ' A' ' 9' ' ' VAL . 51.9 mt -120.79 112.41 18.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.89 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mm -94.31 122.16 45.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.65 126.01 20.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.383 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 -15.44 63.34 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.054 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.26 -172.46 3.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.173 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.59 136.4 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 121.633 0.73 . . . . 0.0 111.672 -174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 75.0 mt -110.28 134.6 51.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.876 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.56 120.47 43.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.0 mt -88.14 -49.21 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -170.69 147.14 2.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.3 pt-20 -90.07 106.71 18.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.19 -40.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.038 -174.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 61.5 mm-40 -122.52 168.05 12.62 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.89 110.96 9.62 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 106.24 -26.7 19.53 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.264 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 95.5 m95 -108.56 114.48 28.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.413 0.625 . . . . 0.0 110.986 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 44.3 m0 -99.09 145.57 27.0 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.965 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -105.32 113.75 27.52 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.1 -177.62 27.7 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.296 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -133.14 129.37 37.79 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.5 tp -84.31 -65.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -104.05 -72.82 0.69 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -137.13 -5.44 1.87 Allowed 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.576 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -99.77 121.42 41.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.62 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 tt -77.64 128.17 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 169.5 32.85 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.81 132.76 36.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -139.87 144.92 40.47 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 58.1 Cg_endo -74.87 125.99 9.76 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.071 1.847 . . . . 0.0 111.851 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 56' ' ' VAL . 15.9 p -60.45 -22.61 63.65 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.465 1.106 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -58.27 -27.1 63.71 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.928 0.891 . . . . 0.0 112.4 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.63 -2.93 40.45 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.851 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 53' ' ' SER . 34.1 m -113.48 158.02 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 8' ' ' LYS . 19.0 ptmt -101.86 -11.6 18.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.143 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 CA--C 1.561 1.37 0 O-C-N 124.117 0.886 . . . . 0.0 108.779 -175.741 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 80.5 mt-30 . . . . . 0 CA--C 1.509 -0.633 0 CA-C-O 121.02 0.438 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 26.7 p -114.92 152.54 32.12 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.828 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -107.6 149.8 27.62 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.764 0.316 . . . . 0.0 110.338 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 41.8 t -91.4 113.38 26.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.225 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.471 HD12 ' HD3' ' A' ' 57' ' ' LYS . 57.7 mt -107.0 -38.92 5.9 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.887 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -107.57 159.47 16.42 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.77 148.6 24.23 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.5 t80 -114.57 -67.96 0.96 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.8 t 67.44 101.95 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -169.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.11 161.61 36.44 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.757 2.305 . . . . 0.0 113.321 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -87.29 -38.19 16.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.57 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 21.1 m120 -119.18 -175.45 2.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.865 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.82 -3.28 49.25 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.435 0.636 . . . . 0.0 109.577 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.56 -52.93 21.71 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.902 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.57 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -60.6 164.05 4.9 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.836 0.826 . . . . 0.0 111.615 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.4 tp -90.7 132.26 35.9 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.6 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.77 158.32 36.52 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-O 121.586 0.707 . . . . 0.0 110.078 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 13' ' ' TYR . 46.6 mt -123.98 101.21 7.12 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.229 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.11 120.43 38.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.1 t -63.67 124.66 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.864 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.03 -12.21 55.89 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.913 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.99 155.06 19.72 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.088 0.47 . . . . 0.0 111.889 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.31 135.78 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.53 119.55 60.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 29.4 t70 -82.53 117.16 22.33 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.96 143.9 15.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -88.8 -57.26 4.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.76 164.2 21.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -92.11 120.65 32.92 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.02 -29.23 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.635 0.731 . . . . 0.0 109.085 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 21.9 mm-40 -130.81 157.82 41.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -77.23 -26.85 53.05 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.727 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -90.06 -37.6 6.7 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.694 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -110.02 109.82 20.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.21 0.529 . . . . 0.0 110.772 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.0 m0 -94.35 163.98 13.2 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.225 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -115.37 114.29 24.91 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.088 0.471 . . . . 0.0 110.637 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.94 177.47 34.66 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -125.12 144.09 50.6 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.936 0.368 . . . . 0.0 110.108 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.38 -68.24 0.8 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -122.7 -49.5 2.0 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.05 -37.13 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.758 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.82 118.51 28.57 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.675 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -91.92 119.17 31.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.07 14.64 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.33 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.4 mp -100.24 146.18 27.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.764 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.09 147.03 22.52 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.545 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 51.4 Cg_endo -75.01 129.3 12.21 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.988 1.792 . . . . 0.0 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 p -75.52 21.09 0.15 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.404 1.082 . . . . 0.0 112.958 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -87.65 -44.06 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.388 0.613 . . . . 0.0 110.008 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.3 -7.53 56.6 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.265 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 9' ' ' VAL . 30.4 m -123.21 146.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.317 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' A' ' 10' ' ' LEU . 4.0 mptp? -127.38 144.93 50.98 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 173.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 30.0 tt0 . . . . . 0 N--CA 1.416 -2.135 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 . . . . . 0 N--CA 1.441 -0.907 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.37 128.83 54.44 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -83.94 147.31 27.55 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.668 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.5 t -90.56 133.72 31.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HD3' ' A' ' 57' ' ' LYS . 62.1 mt -95.1 -58.6 2.1 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.758 0.823 . . . . 0.0 109.526 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.12 160.18 24.24 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.088 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.4 158.58 24.58 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.166 0.508 . . . . 0.0 110.156 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.3 -58.3 2.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t 71.4 105.4 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.537 1.135 . . . . 0.0 109.105 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.23 154.86 43.45 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.279 1.986 . . . . 0.0 111.448 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -83.74 -29.46 27.45 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.475 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 13.2 m120 -112.13 -80.37 0.59 Allowed 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.504 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 167.6 -24.96 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.296 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.68 -21.72 61.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.475 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -74.7 150.98 39.28 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.12 117.65 20.35 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.973 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.18 126.75 28.72 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.342 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 51' ' ' PHE . 38.7 mt -91.9 117.02 29.4 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.47 114.11 28.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.228 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.76 127.08 26.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.348 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.97 -9.86 75.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.458 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.66 178.99 4.4 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.32 129.39 73.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.775 0.321 . . . . 0.0 110.926 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.86 141.08 15.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 123.535 0.734 . . . . 0.0 110.696 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.72 95.72 9.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.93 144.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.579 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.8 mt -113.74 -54.78 4.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.91 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -155.65 160.99 40.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 8.6 pt-20 -100.91 142.92 31.7 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 m -100.35 -25.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 44.7 mt-10 -139.11 164.82 28.78 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.03 -39.14 91.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 123.548 0.53 . . . . 0.0 110.16 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.83 -40.19 5.98 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.039 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -92.14 105.87 18.01 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.768 0.794 . . . . 0.0 111.638 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 43.6 m0 -93.74 153.49 18.3 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.014 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -109.7 120.5 42.69 Favored 'General case' 0 C--O 1.261 1.705 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.2 177.93 36.45 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -134.55 166.46 22.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.56 -60.53 0.79 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.36 0.6 . . . . 0.0 109.617 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -114.27 -69.74 0.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -128.22 -29.31 2.51 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.993 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -85.82 121.81 28.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.074 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 tp -98.93 107.01 19.33 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.75 -169.53 18.11 Favored Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 112.653 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 71.7 mt -96.93 146.22 25.16 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.837 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 23' ' ' LEU . 44.1 p90 -147.42 147.5 28.38 Favored Pre-proline 0 C--N 1.299 -1.614 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.736 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.81 123.23 7.83 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.362 2.041 . . . . 0.0 111.701 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 56' ' ' VAL . 32.9 t -71.51 -10.96 60.57 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.24 -21.66 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.639 -0.663 . . . . 0.0 112.35 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.69 10.39 41.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.813 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 53' ' ' SER . 21.7 m -133.4 155.87 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.723 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' A' ' 10' ' ' LEU . 4.3 mptp? -122.45 126.43 47.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.554 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--N 1.312 -1.04 0 C-N-CA 124.416 1.086 . . . . 0.0 111.89 -175.127 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 120.948 0.404 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.89 149.04 24.61 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.328 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -98.64 143.01 29.49 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.397 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 56' ' ' VAL . 21.6 t -84.97 108.03 16.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.957 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.36 -34.6 17.55 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.861 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.27 150.28 50.99 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.467 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -80.49 158.43 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.142 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -150.16 110.06 4.1 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.751 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -97.95 107.55 41.22 Favored Pre-proline 0 N--CA 1.411 -2.377 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 63.4 Cg_exo -48.33 154.67 2.44 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 124.543 3.495 . . . . 0.0 114.457 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.13 -21.86 25.71 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.252 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 91.2 m-20 -130.95 -161.72 1.15 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -105.18 7.05 33.52 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.527 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.49 -43.26 40.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.824 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.16 159.16 30.96 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.574 0.702 . . . . 0.0 111.041 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.61 143.78 28.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 20.3 mt-10 -81.91 120.57 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.1 mt -97.72 120.47 38.16 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.138 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.83 122.59 69.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.24 130.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 123.98 0.912 . . . . 0.0 112.827 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.25 -3.62 64.19 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.528 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.2 -178.48 3.67 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.18 138.74 53.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.694 0.798 . . . . 0.0 108.984 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.54 134.11 52.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.626 0.251 . . . . 0.0 110.452 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.65 96.7 4.9 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.51 129.54 36.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.256 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.7 mt -98.59 -61.35 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.5 176.81 6.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.7 pt-20 -108.32 128.3 54.62 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.983 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.97 -35.54 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.58 170.0 16.72 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.255 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.42 93.95 3.02 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.38 -35.79 3.1 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -99.84 114.18 27.19 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.334 0.588 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.9 m0 -99.66 158.37 15.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -111.99 120.38 41.69 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.23 33.85 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.536 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.9 m -105.92 128.37 53.74 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -81.25 -60.17 2.38 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -140.22 -65.72 0.45 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.033 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.83 -17.21 12.1 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.513 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -120.67 142.45 49.46 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.262 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 49' ' ' GLY . 5.7 tt -94.35 135.75 35.42 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 48' ' ' LEU . . . -150.45 170.2 30.36 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.068 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 69.5 mt -101.39 131.08 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -139.81 146.14 45.9 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.236 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.74 133.24 8.01 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.142 1.895 . . . . 0.0 111.366 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -80.44 42.58 0.6 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.781 0.801 . . . . 0.0 111.348 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -102.22 -40.56 6.72 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.22 -9.42 45.35 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 9' ' ' VAL . 35.9 m -127.01 140.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.734 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -124.6 142.08 51.62 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.628 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.378 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 51.2 mt-30 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-O 120.862 0.363 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.7 p -120.74 155.94 32.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.258 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.6 mttm -105.72 140.13 39.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.572 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 23' ' ' LEU . 99.8 t -78.79 118.79 26.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.139 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -101.82 -34.38 9.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.809 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -124.52 154.39 40.63 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.81 154.02 28.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -113.58 -52.46 2.75 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.624 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m 58.67 88.35 0.12 Allowed Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 110.487 -173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.19 153.46 39.39 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.05 2.5 . . . . 0.0 113.173 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.62 -17.68 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.73 -167.08 1.92 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -105.29 5.91 32.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.66 -31.18 16.72 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.225 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 2.8 mp0 -74.85 178.67 5.36 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.382 0.61 . . . . 0.0 110.134 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.7 tp -94.73 136.25 35.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -84.49 117.06 23.44 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.976 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 9' ' ' VAL . 26.7 mt -89.96 108.42 19.71 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.696 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.22 127.62 41.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.7 p -68.54 128.14 31.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 CA-C-O 121.803 0.811 . . . . 0.0 112.253 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.67 87.59 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.882 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 3.7 t0 -87.25 169.24 12.49 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.476 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.7 t -114.27 129.36 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.322 0.649 . . . . 0.0 110.709 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.31 134.83 53.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 122.972 0.509 . . . . 0.0 110.863 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 33.5 t70 -86.69 105.19 16.76 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 t -84.85 121.29 36.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.101 -176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -90.09 -50.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.76 152.86 18.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.158 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.9 pt-20 -90.1 124.43 34.8 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 168.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.49 -34.99 7.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.818 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -138.29 153.51 49.04 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -71.54 112.61 7.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.225 0.536 . . . . 0.0 109.856 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 110.32 -13.02 30.95 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.423 -177.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -126.7 107.02 9.79 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.38 0.609 . . . . 0.0 110.876 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.3 m0 -94.54 143.53 26.34 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -107.56 114.8 29.04 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.03 170.79 34.37 Favored Glycine 0 N--CA 1.42 -2.404 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -118.5 141.82 48.19 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.84 -54.92 4.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -132.54 -59.99 0.9 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.117 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.06 -21.6 2.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -101.91 115.64 30.98 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.955 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.97 108.54 5.94 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.83 173.2 16.56 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.954 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 18.1 tp -107.35 139.75 41.34 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -150.64 147.58 21.61 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 121.365 -0.134 . . . . 0.0 110.984 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 41.0 Cg_endo -71.3 129.45 15.99 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.089 1.859 . . . . 0.0 111.3 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -68.02 -22.29 64.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.7 0.8 . . . . 0.0 112.844 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -57.32 -33.06 67.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.964 0.506 . . . . 0.0 112.36 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -90.48 -6.66 54.57 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 27.3 m -118.48 137.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.229 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 13.5 mptt -116.19 131.87 56.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.802 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--N 1.293 -1.874 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.995 -174.456 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.445 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -100.66 -6.24 25.45 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 122.416 -0.461 . . . . 0.0 111.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.6 mmt 60.87 38.82 17.56 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.96 141.39 45.22 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.234 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -102.54 159.29 15.57 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.312 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -68.72 141.33 55.31 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.905 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.9 p -110.01 131.28 55.2 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.118 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 50.2 tttp -91.68 148.25 22.4 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 56' ' ' VAL . 43.1 t -88.22 114.47 26.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -101.02 -34.26 9.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 123.802 0.689 . . . . 0.0 111.513 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -121.79 160.68 24.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.271 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.71 131.18 35.26 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.601 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -131.46 113.01 13.19 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.214 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 31.6 m -94.1 106.75 24.18 Favored Pre-proline 0 N--CA 1.403 -2.783 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 37.1 Cg_endo -64.01 149.89 89.54 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.309 2.673 . . . . 0.0 113.836 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 16' ' ' GLN . 12.9 mt-30 -88.45 -30.04 19.73 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.357 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 38.0 m-80 -130.0 156.61 44.19 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.88 -7.39 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.942 0.877 . . . . 0.0 110.63 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.74 -21.72 60.12 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 63.3 mt-10 -84.24 126.02 32.76 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.26 132.1 44.44 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.397 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.25 114.32 7.39 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 122.164 0.983 . . . . 0.0 111.791 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.4 mt -87.0 104.79 16.64 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.322 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.67 120.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.613 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.93 121.04 12.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 -28.61 7.93 Favored Glycine 0 N--CA 1.427 -1.922 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.332 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.3 175.59 8.82 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.765 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 14.1 p -124.14 137.72 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.6 mt -109.28 130.71 61.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 121.136 0.493 . . . . 0.0 109.957 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.1 107.25 17.75 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.8 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.117 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.39 -59.64 2.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -164.22 157.67 18.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.5 139.59 30.54 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -106.48 -44.21 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.5 70.01 1.38 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.574 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 52.33 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.959 1.704 . . . . 0.0 113.585 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -71.5 -42.84 54.85 Favored Glycine 0 N--CA 1.419 -2.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.362 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -89.31 111.93 22.88 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.81 0.814 . . . . 0.0 111.949 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -101.2 164.27 11.87 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.788 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 m -124.78 120.62 32.28 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.946 0.403 . . . . 0.0 110.288 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.79 178.33 36.82 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.7 t -129.15 138.68 51.92 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.336 0.589 . . . . 0.0 110.827 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -111.01 101.03 9.62 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 68.39 -78.93 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.483 1.113 . . . . 0.0 113.068 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -131.14 -6.79 3.87 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -107.02 125.54 51.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.218 0.533 . . . . 0.0 110.923 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.18 136.53 37.56 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.28 -179.05 39.96 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 118.903 -1.618 . . . . 0.0 113.28 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 72.6 mt -99.17 137.71 37.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -141.63 141.54 22.96 Favored Pre-proline 0 C--N 1.291 -1.974 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.166 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 61.1 Cg_endo -78.71 128.88 8.86 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.378 2.052 . . . . 0.0 112.552 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 p -72.81 21.6 0.07 Allowed 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.152 1.381 . . . . 0.0 113.271 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.54 -42.71 10.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -90.27 -12.04 39.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.702 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 9' ' ' VAL . 32.6 m -121.6 140.07 46.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.976 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -121.39 141.71 50.71 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.744 0.307 . . . . 0.0 110.92 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -84.02 76.89 10.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.8 pt? -114.48 7.51 16.23 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.78 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--N 1.276 -2.587 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.048 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 m -71.68 121.74 19.37 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -8.09 57.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.275 . . . . 0.0 111.168 -175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.23 4.19 Favored Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.726 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.12 13.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.57 135.89 43.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.626 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 25.7 p -111.48 152.39 27.5 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.971 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -100.49 144.9 28.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.69 109.73 23.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.56 -38.91 11.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.203 0.525 . . . . 0.0 110.438 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 90.4 m-85 -127.75 156.24 42.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -99.34 162.44 13.04 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.843 -175.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 15' ' ' PRO . 41.3 t80 -137.38 124.05 21.06 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 22.9 t -91.53 105.6 13.64 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 18.4 Cg_endo -60.78 141.2 94.18 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 123.198 2.599 . . . . 0.0 112.671 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.2 -36.79 69.28 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.01 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 16.2 m-80 -129.39 161.87 29.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.97 4.36 19.81 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.68 -19.43 45.2 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 1.4 mp0 -86.03 139.26 31.32 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.037 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -75.16 129.67 37.92 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.97 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.0 109.01 2.81 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-O 122.22 1.009 . . . . 0.0 110.56 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 43.3 mt -84.34 112.96 20.8 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 113.726 -1.579 . . . . 0.0 108.494 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -111.64 126.55 69.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 12' ' ' ASP . 43.4 t -61.09 128.33 22.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 O-C-N 123.428 0.455 . . . . 0.0 111.183 -176.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.71 -39.25 2.8 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.259 -0.972 . . . . 0.0 114.128 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -86.36 176.31 7.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.895 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.3 141.04 30.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 124.131 0.972 . . . . 0.0 109.319 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 74.8 mt -112.92 131.63 63.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.76 106.78 17.25 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -93.56 140.5 16.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.381 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -80.52 -64.8 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -173.56 170.16 4.16 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 12.7 pt-20 -78.38 127.98 32.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.07 -31.65 3.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.914 0.388 . . . . 0.0 111.38 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 43.8 mt-10 -137.89 168.31 19.95 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.77 91.89 1.97 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.373 0.606 . . . . 0.0 110.545 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 116.73 -11.76 15.55 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.938 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 90.6 m95 -117.89 116.95 27.98 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.352 0.596 . . . . 0.0 110.402 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 40.1 m0 -105.58 155.33 19.31 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 t -118.79 139.73 51.1 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.07 -172.26 44.79 Favored Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.7 t -130.53 146.1 51.99 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.79 -62.28 1.59 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -176.11 22.81 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 125.514 1.526 . . . . 0.0 107.295 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -172.11 -67.73 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.317 -169.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.87 120.03 25.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt -109.83 133.25 53.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.48 -153.19 8.32 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.969 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.5 mm? -111.43 144.8 40.05 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -150.41 145.21 18.25 Favored Pre-proline 0 C--N 1.298 -1.671 0 CA-C-N 118.23 0.468 . . . . 0.0 111.3 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 54.7 Cg_endo -73.9 130.47 14.52 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.05 1.833 . . . . 0.0 110.766 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -78.99 17.34 0.76 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -75.05 -46.72 32.97 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.748 0.785 . . . . 0.0 109.173 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 54.8 m-85 -87.33 -6.95 58.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.084 -170.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.02 142.32 38.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.853 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -122.27 128.82 51.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.0 109.94 7.9 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.526 0.73 . . . . 0.0 109.927 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mp 62.0 -173.15 0.15 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.665 0.786 . . . . 0.0 111.957 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -100.17 -28.25 13.11 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 117.348 0.574 . . . . 0.0 109.872 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.7 tpt -125.03 139.21 54.01 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.061 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.95 102.83 1.83 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.513 ' HD3' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -77.07 126.63 31.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 90.4 mt-30 -123.82 170.05 10.95 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.53 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.7 p -144.27 135.26 25.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.391 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.43 148.33 24.86 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 O-C-N 124.156 0.91 . . . . 0.0 110.976 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.43 -47.77 6.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.704 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.25 146.46 45.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.434 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.44 138.97 39.56 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.154 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 19.2 t80 -113.48 -59.44 2.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.257 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t 64.0 100.69 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -170.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 44.5 Cg_endo -61.51 158.95 33.94 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.594 2.196 . . . . 0.0 112.781 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -92.91 -39.87 10.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -115.06 -173.58 2.34 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.828 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -85.18 -13.49 49.89 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.51 -43.18 63.93 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.582 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.9 mp0 -72.34 147.8 45.95 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.951 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.12 147.72 28.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.23 0.538 . . . . 0.0 110.475 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -71.76 109.57 5.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.937 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 43.6 mt -102.67 110.76 22.8 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.038 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.93 134.42 62.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.81 127.14 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.609 0.719 . . . . 0.0 112.116 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.26 -4.32 70.33 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.257 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -95.99 169.77 9.75 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 117.882 0.841 . . . . 0.0 109.567 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.32 139.43 51.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.508 0.67 . . . . 0.0 111.121 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.4 138.22 46.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.127 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 11.2 t70 -94.3 93.18 7.58 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG13 ' HD3' ' A' ' 5' ' ' ARG . 7.7 p -77.85 115.15 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.71 0.767 . . . . 0.0 110.467 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 48' ' ' LEU . 50.6 mt -71.24 -57.97 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.796 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -178.37 7.22 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.577 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -129.29 117.78 21.22 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.153 0.502 . . . . 0.0 111.386 -175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.2 -24.02 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.94 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -133.68 170.01 16.19 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.497 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.27 -45.9 24.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -84.58 -28.01 33.86 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.499 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.405 ' CZ3' ' HD3' ' A' ' 52' ' ' PRO . 91.7 m95 -115.24 117.28 30.06 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.494 0.664 . . . . 0.0 111.618 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -105.69 150.73 25.21 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.454 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 104.02 13.23 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.885 0.85 . . . . 0.0 110.797 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 167.42 24.37 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.962 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 t -114.09 131.49 56.38 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.08 -63.66 1.22 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.05 -72.12 0.7 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -123.64 -14.43 7.29 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.417 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -84.21 115.8 22.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 HD12 ' A' ' 32' ' ' ILE . 64.6 tp -85.98 124.22 32.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.11 166.3 26.73 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.516 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 tp -97.72 138.18 35.48 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.29 149.9 33.19 Favored Pre-proline 0 C--N 1.295 -1.766 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.82 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 53.6 Cg_endo -71.34 122.01 8.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.715 2.277 . . . . 0.0 111.861 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 p -69.46 -10.64 58.9 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.774 0.83 . . . . 0.0 113.193 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.16 -15.48 60.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 111.737 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -101.99 7.01 41.47 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 121.363 -0.836 . . . . 0.0 112.124 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.67 167.22 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.88 145.97 48.77 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -85.55 144.64 27.79 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.238 0.542 . . . . 0.0 112.062 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.48 168.36 20.03 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.923 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.694 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.429 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -114.32 171.79 7.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.3 tpp -84.06 96.65 8.96 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.86 107.46 1.12 Allowed Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -88.75 -179.71 6.06 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 111.426 0.158 . . . . 0.0 111.426 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.463 ' O ' HD13 ' A' ' 59' ' ' LEU . 9.6 mt-30 -51.39 124.22 11.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 124.834 1.334 . . . . 0.0 108.676 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.7 p -83.24 131.44 35.1 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.031 -172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' O ' ' HD3' ' A' ' 57' ' ' LYS . 49.6 mttm -87.05 144.22 26.98 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.65 141.91 15.03 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' CD2' ' HD2' ' A' ' 57' ' ' LYS . 34.0 mt -99.94 -54.78 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 111.099 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -127.92 164.53 22.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.003 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.29 149.92 35.33 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.536 0.523 . . . . 0.0 110.856 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 79.8 t80 -146.75 113.43 6.03 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 26.5 t -103.84 108.0 58.4 Favored Pre-proline 0 N--CA 1.399 -3.021 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 29.2 Cg_endo -62.11 163.53 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.293 2.662 . . . . 0.0 112.732 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -92.87 -43.69 8.85 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -107.87 -173.14 2.21 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.14 15.64 25.31 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.24 0.543 . . . . 0.0 109.545 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.77 -36.77 13.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.371 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.3 mp0 -80.86 171.15 15.37 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 46.0 tp -106.24 139.81 40.17 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.4 164.17 26.79 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.573 0.701 . . . . 0.0 111.371 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 72.9 mt -133.27 124.39 27.24 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.28 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.8 mt -123.44 123.78 68.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.09 116.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.453 0.644 . . . . 0.0 111.039 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.87 -8.96 29.71 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.398 -0.905 . . . . 0.0 112.966 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.33 177.88 5.81 Favored 'General case' 0 C--O 1.251 1.175 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.15 134.38 62.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.515 0.726 . . . . 0.0 109.061 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -113.08 134.39 55.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.5 94.55 4.97 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.93 104.24 7.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.843 0.83 . . . . 0.0 109.136 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 33' ' ' GLU . 65.2 mt -81.49 -58.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.186 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 32' ' ' ILE . 20.8 mm-40 -138.55 169.27 18.1 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.457 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -115.96 137.51 52.05 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.68 -26.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.288 0.566 . . . . 0.0 110.489 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -138.07 178.15 7.34 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -84.91 -17.22 38.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.01 -1.36 20.82 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.523 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -136.13 124.63 23.54 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.018 0.437 . . . . 0.0 110.879 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 52.5 m0 -113.86 158.24 21.31 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.224 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -103.99 111.22 23.68 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.19 165.07 28.98 Favored Glycine 0 N--CA 1.424 -2.161 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.756 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 4.9 t -110.17 129.44 55.71 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -90.85 -74.74 0.49 Allowed 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.9 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.52 -21.68 12.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.245 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -165.9 -42.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.078 0.466 . . . . 0.0 110.441 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.8 mptm? -94.47 140.55 29.68 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.9 tp -90.43 101.36 14.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.801 -1.545 . . . . 0.0 106.948 175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.17 177.29 18.59 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.794 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.6 mp -92.24 128.0 37.93 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.7 p90 -126.47 145.88 54.57 Favored Pre-proline 0 C--N 1.288 -2.082 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.687 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.48 113.11 3.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.614 2.209 . . . . 0.0 111.728 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.94 -24.44 62.53 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.875 1.27 . . . . 0.0 113.265 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.89 -22.33 64.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -99.39 16.19 23.91 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.818 -0.551 . . . . 0.0 111.959 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.49 162.15 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD2' ' CD2' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -119.42 126.2 50.78 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.161 175.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.01 133.25 40.45 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.88 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 6' ' ' GLN . 7.3 mp -96.88 129.89 44.25 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.566 0.222 . . . . 0.0 110.748 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 173.244 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.977 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m -81.26 91.61 6.23 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.264 0.554 . . . . 0.0 109.71 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp -92.87 -29.75 15.77 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.065 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.45 139.78 5.08 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.487 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -103.0 167.62 9.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.441 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.5 pt20 -50.29 135.83 20.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.891 0.853 . . . . 0.0 111.929 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.0 p -121.63 140.48 52.21 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.861 -172.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -93.61 154.39 17.87 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 56' ' ' VAL . 48.6 t -82.12 129.87 36.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.527 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -96.14 -49.07 5.39 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.147 0.499 . . . . 0.0 109.848 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -130.8 147.88 52.51 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.63 135.41 45.49 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.499 0.5 . . . . 0.0 110.554 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 40.4 t80 -114.92 109.46 18.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.329 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -91.18 105.7 13.47 Favored Pre-proline 0 N--CA 1.403 -2.821 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 34.3 Cg_endo -68.47 163.2 37.58 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.055 2.503 . . . . 0.0 114.021 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.96 -33.1 39.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.205 1.002 . . . . 0.0 109.004 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -125.34 -168.5 1.84 Allowed 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -104.75 18.37 22.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.53 -47.01 13.65 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.149 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.7 mp0 -68.09 159.14 31.51 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 tp -80.87 125.72 30.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.58 122.77 20.36 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 122.015 0.912 . . . . 0.0 112.016 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 47.0 mt -96.26 108.74 21.27 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 113.866 -1.515 . . . . 0.0 109.018 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 125.9 66.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.87 136.29 26.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-O 121.27 0.557 . . . . 0.0 110.558 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.02 -22.95 15.03 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.661 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.85 172.5 7.4 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.457 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.4 129.14 64.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 124.509 1.123 . . . . 0.0 108.802 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.51 132.65 60.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.11 105.67 17.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 12.8 p -86.71 148.51 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.209 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.1 -55.43 6.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.83 -176.32 1.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.18 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 11.9 pt-20 -107.39 141.66 38.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -96.46 -25.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.058 0.456 . . . . 0.0 110.779 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -146.33 151.98 38.38 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.86 94.23 0.82 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.648 0.737 . . . . 0.0 109.246 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 137.01 -23.13 3.22 Favored Glycine 0 N--CA 1.415 -2.713 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.905 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -124.75 114.8 19.76 Favored 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.609 0.719 . . . . 0.0 112.093 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 21.7 m0 -99.28 142.96 30.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.231 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -105.24 106.56 17.12 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 31' ' ' VAL . . . -145.98 167.73 27.72 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.28 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 t -111.79 131.23 55.47 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.656 0.741 . . . . 0.0 110.644 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -71.75 -34.51 69.55 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.246 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -164.27 -68.61 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.749 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.14 -16.23 6.55 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.03 110.23 20.46 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.19 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -89.55 131.22 35.68 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.6 174.92 35.73 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.804 -1.189 . . . . 0.0 112.339 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.14 136.36 37.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -142.64 145.14 32.97 Favored Pre-proline 0 C--N 1.289 -2.034 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 56.2 Cg_endo -72.14 129.8 15.62 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 122.06 1.84 . . . . 0.0 112.17 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 5.6 p -79.24 15.34 1.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 52' ' ' PRO . 27.6 p-10 -95.1 -15.34 23.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.04 0.447 . . . . 0.0 109.887 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.22 6.74 28.92 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.051 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 9' ' ' VAL . 27.1 m -142.69 144.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 58' ' ' GLU . 11.4 ptmt -100.75 -107.64 0.22 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.294 172.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' LYS . 40.5 tt0 -171.03 145.85 2.36 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 6' ' ' GLN . 4.5 pp -99.78 166.68 10.97 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.318 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.283 -2.283 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.951 -174.73 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.2 t -103.41 -43.21 5.48 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 117.414 0.607 . . . . 0.0 109.475 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 tpt -148.87 162.57 39.57 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.52 -35.78 92.26 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 73.73 168.98 0.31 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.866 1.666 . . . . 0.0 112.894 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.605 ' HB2' HD21 ' A' ' 59' ' ' LEU . 45.4 mt-30 -137.33 -176.5 4.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 9.5 p -148.01 137.34 22.22 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.952 177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HB2' ' HD3' ' A' ' 57' ' ' LYS . 3.5 mptp? -83.14 149.27 26.97 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 23' ' ' LEU . 61.0 t -97.08 121.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.995 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.77 -47.04 7.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.0 110.897 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.82 146.53 45.62 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.54 162.22 22.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.067 0.461 . . . . 0.0 110.906 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -146.03 127.11 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.262 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 t -104.78 106.32 54.46 Favored Pre-proline 0 N--CA 1.416 -2.145 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' A' ' 20' ' ' GLU . 37.1 Cg_endo -68.86 171.72 12.98 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 123.433 2.755 . . . . 0.0 114.445 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -86.71 -48.23 8.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -123.3 -177.83 3.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.969 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -85.86 -6.28 59.11 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.695 0.283 . . . . 0.0 110.393 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.14 -32.84 71.02 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 1.6 mp0 -77.22 173.06 12.31 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.27 130.33 55.97 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.42 156.95 38.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' HG11 ' A' ' 9' ' ' VAL . 51.9 mt -120.79 112.41 18.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.89 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mm -94.31 122.16 45.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.65 126.01 20.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.383 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 -15.44 63.34 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.054 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.26 -172.46 3.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.173 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.59 136.4 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 121.633 0.73 . . . . 0.0 111.672 -174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 7' ' ' CYS . 75.0 mt -110.28 134.6 51.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.876 177.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.56 120.47 43.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.0 mt -88.14 -49.21 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -170.69 147.14 2.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.3 pt-20 -90.07 106.71 18.66 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.19 -40.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.038 -174.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 39' ' ' TRP . 61.5 mm-40 -122.52 168.05 12.62 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.89 110.96 9.62 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 106.24 -26.7 19.53 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.264 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 95.5 m95 -108.56 114.48 28.33 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.413 0.625 . . . . 0.0 110.986 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 44.3 m0 -99.09 145.57 27.0 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.965 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -105.32 113.75 27.52 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.1 -177.62 27.7 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.296 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -133.14 129.37 37.79 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.5 tp -84.31 -65.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -104.05 -72.82 0.69 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -137.13 -5.44 1.87 Allowed 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.576 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -99.77 121.42 41.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.62 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 tt -77.64 128.17 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 169.5 32.85 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.81 132.76 36.7 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -139.87 144.92 40.47 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 58.1 Cg_endo -74.87 125.99 9.76 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.071 1.847 . . . . 0.0 111.851 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 56' ' ' VAL . 15.9 p -60.45 -22.61 63.65 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.465 1.106 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -58.27 -27.1 63.71 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.928 0.891 . . . . 0.0 112.4 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.63 -2.93 40.45 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.851 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 53' ' ' SER . 34.1 m -113.48 158.02 13.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 8' ' ' LYS . 19.0 ptmt -101.86 -11.6 18.91 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.143 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 67.74 174.02 0.27 Allowed 'General case' 0 CA--C 1.561 1.37 0 O-C-N 124.117 0.886 . . . . 0.0 108.779 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' A' ' 6' ' ' GLN . 3.6 pp -143.39 177.65 8.29 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.406 -0.809 . . . . 0.0 110.338 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--N 1.293 -1.86 0 O-C-N 123.763 0.664 . . . . 0.0 109.5 -174.606 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -102.34 -10.24 19.66 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.864 0.332 . . . . 0.0 111.753 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 69.64 -74.45 0.08 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.793 1.237 . . . . 0.0 113.016 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.04 -165.44 12.02 Favored Glycine 0 C--N 1.296 -1.641 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -140.87 124.2 16.67 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 80.5 mt-30 -130.88 136.59 48.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.02 0.438 . . . . 0.0 110.779 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 26.7 p -114.92 152.54 32.12 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.828 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -107.6 149.8 27.62 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.764 0.316 . . . . 0.0 110.338 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 41.8 t -91.4 113.38 26.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.225 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.471 HD12 ' HD3' ' A' ' 57' ' ' LYS . 57.7 mt -107.0 -38.92 5.9 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.887 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -107.57 159.47 16.42 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.77 148.6 24.23 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' HD12 ' A' ' 23' ' ' LEU . 9.5 t80 -114.57 -67.96 0.96 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.8 t 67.44 101.95 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -169.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.11 161.61 36.44 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.757 2.305 . . . . 0.0 113.321 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -87.29 -38.19 16.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.57 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 21.1 m120 -119.18 -175.45 2.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.325 -1.307 . . . . 0.0 107.865 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -94.82 -3.28 49.25 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.435 0.636 . . . . 0.0 109.577 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.56 -52.93 21.71 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.902 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.57 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -60.6 164.05 4.9 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.836 0.826 . . . . 0.0 111.615 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.4 tp -90.7 132.26 35.9 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.6 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.77 158.32 36.52 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-O 121.586 0.707 . . . . 0.0 110.078 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 13' ' ' TYR . 46.6 mt -123.98 101.21 7.12 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.229 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -90.11 120.43 38.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 81.1 t -63.67 124.66 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.864 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.03 -12.21 55.89 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.913 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.99 155.06 19.72 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.088 0.47 . . . . 0.0 111.889 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.31 135.78 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -111.53 119.55 60.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 29.4 t70 -82.53 117.16 22.33 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.96 143.9 15.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -88.8 -57.26 4.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -164.76 164.2 21.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 12.5 pt-20 -92.11 120.65 32.92 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.02 -29.23 9.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.635 0.731 . . . . 0.0 109.085 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 21.9 mm-40 -130.81 157.82 41.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -77.23 -26.85 53.05 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.727 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . -90.06 -37.6 6.7 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.694 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -110.02 109.82 20.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.21 0.529 . . . . 0.0 110.772 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.0 m0 -94.35 163.98 13.2 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.225 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -115.37 114.29 24.91 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.088 0.471 . . . . 0.0 110.637 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.94 177.47 34.66 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -125.12 144.09 50.6 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.936 0.368 . . . . 0.0 110.108 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.38 -68.24 0.8 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -122.7 -49.5 2.0 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -133.05 -37.13 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.758 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -88.82 118.51 28.57 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.675 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -91.92 119.17 31.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.07 14.64 Favored Glycine 0 N--CA 1.415 -2.704 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.33 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.4 mp -100.24 146.18 27.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.764 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.09 147.03 22.52 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.545 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 51.4 Cg_endo -75.01 129.3 12.21 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.988 1.792 . . . . 0.0 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 p -75.52 21.09 0.15 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.404 1.082 . . . . 0.0 112.958 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -87.65 -44.06 11.49 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.388 0.613 . . . . 0.0 110.008 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.3 -7.53 56.6 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.265 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 9' ' ' VAL . 30.4 m -123.21 146.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.317 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HD3' HD12 ' A' ' 10' ' ' LEU . 4.0 mptp? -127.38 144.93 50.98 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 173.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 30.0 tt0 -90.0 109.12 20.17 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.91 123.31 33.15 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.854 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.488 -178.278 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.19 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 t -80.51 95.78 6.59 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.4 mtp -99.62 107.39 19.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.083 0.468 . . . . 0.0 111.019 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.35 -95.56 0.25 Allowed Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.501 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 60.94 3.89 0.72 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.127 1.371 . . . . 0.0 113.422 -176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.0 167.85 12.09 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.37 128.83 54.44 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -83.94 147.31 27.55 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.668 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.5 t -90.56 133.72 31.53 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HD3' ' A' ' 57' ' ' LYS . 62.1 mt -95.1 -58.6 2.1 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.758 0.823 . . . . 0.0 109.526 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.12 160.18 24.24 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.088 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.4 158.58 24.58 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.166 0.508 . . . . 0.0 110.156 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.3 -58.3 2.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t 71.4 105.4 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 124.537 1.135 . . . . 0.0 109.105 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.23 154.86 43.45 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.279 1.986 . . . . 0.0 111.448 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -83.74 -29.46 27.45 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.475 ' HB2' ' OE1' ' A' ' 20' ' ' GLU . 13.2 m120 -112.13 -80.37 0.59 Allowed 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.504 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 167.6 -24.96 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.296 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.68 -21.72 61.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' OE1' ' HB2' ' A' ' 17' ' ' ASN . 1.6 mp0 -74.7 150.98 39.28 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.12 117.65 20.35 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.973 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.18 126.75 28.72 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.342 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 51' ' ' PHE . 38.7 mt -91.9 117.02 29.4 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.47 114.11 28.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.228 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.76 127.08 26.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.348 -174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.97 -9.86 75.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.458 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -105.66 178.99 4.4 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.32 129.39 73.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.775 0.321 . . . . 0.0 110.926 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.86 141.08 15.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 123.535 0.734 . . . . 0.0 110.696 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.72 95.72 9.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.93 144.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.579 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.8 mt -113.74 -54.78 4.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.91 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -155.65 160.99 40.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 8.6 pt-20 -100.91 142.92 31.7 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 m -100.35 -25.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 44.7 mt-10 -139.11 164.82 28.78 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.03 -39.14 91.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 123.548 0.53 . . . . 0.0 110.16 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.83 -40.19 5.98 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.039 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -92.14 105.87 18.01 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.768 0.794 . . . . 0.0 111.638 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 43.6 m0 -93.74 153.49 18.3 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.014 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -109.7 120.5 42.69 Favored 'General case' 0 C--O 1.261 1.705 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.2 177.93 36.45 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -134.55 166.46 22.84 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.56 -60.53 0.79 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.36 0.6 . . . . 0.0 109.617 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -114.27 -69.74 0.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -128.22 -29.31 2.51 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.993 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -85.82 121.81 28.99 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.074 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 tp -98.93 107.01 19.33 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.75 -169.53 18.11 Favored Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 119.094 -1.527 . . . . 0.0 112.653 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 71.7 mt -96.93 146.22 25.16 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.837 -176.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 23' ' ' LEU . 44.1 p90 -147.42 147.5 28.38 Favored Pre-proline 0 C--N 1.299 -1.614 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.736 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.81 123.23 7.83 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.362 2.041 . . . . 0.0 111.701 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 56' ' ' VAL . 32.9 t -71.51 -10.96 60.57 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.24 -21.66 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.639 -0.663 . . . . 0.0 112.35 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.69 10.39 41.44 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.813 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 53' ' ' SER . 21.7 m -133.4 155.87 41.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.723 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.5 ' HD3' HD11 ' A' ' 10' ' ' LEU . 4.3 mptp? -122.45 126.43 47.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.554 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.05 24.99 0.73 Allowed 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 124.416 1.086 . . . . 0.0 111.89 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.09 133.51 49.75 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.981 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.286 -2.157 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.473 -179.737 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.828 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -156.8 -171.01 3.5 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ptm -74.76 84.52 2.15 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.342 1.068 . . . . 0.0 110.528 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.14 128.19 2.1 Favored Glycine 0 N--CA 1.403 -3.552 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -78.03 120.91 23.53 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -68.03 140.01 56.31 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.627 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 p -101.89 149.04 24.61 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.328 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -98.64 143.01 29.49 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.397 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 56' ' ' VAL . 21.6 t -84.97 108.03 16.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.957 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.36 -34.6 17.55 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.861 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.27 150.28 50.99 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.467 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -80.49 158.43 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.142 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -150.16 110.06 4.1 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.751 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -97.95 107.55 41.22 Favored Pre-proline 0 N--CA 1.411 -2.377 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 63.4 Cg_exo -48.33 154.67 2.44 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 124.543 3.495 . . . . 0.0 114.457 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -87.13 -21.86 25.71 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.252 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' PRO . 91.2 m-20 -130.95 -161.72 1.15 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -105.18 7.05 33.52 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.527 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.49 -43.26 40.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.824 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.16 159.16 30.96 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.574 0.702 . . . . 0.0 111.041 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.3 tp -85.61 143.78 28.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 20.3 mt-10 -81.91 120.57 25.37 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.1 mt -97.72 120.47 38.16 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.138 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.83 122.59 69.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.24 130.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 123.98 0.912 . . . . 0.0 112.827 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.25 -3.62 64.19 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.528 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -104.2 -178.48 3.67 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.17 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.18 138.74 53.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.694 0.798 . . . . 0.0 108.984 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.54 134.11 52.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 120.626 0.251 . . . . 0.0 110.452 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.65 96.7 4.9 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.51 129.54 36.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.256 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.7 mt -98.59 -61.35 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.5 176.81 6.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.7 pt-20 -108.32 128.3 54.62 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.983 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.97 -35.54 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -139.58 170.0 16.72 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.255 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.42 93.95 3.02 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.38 -35.79 3.1 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -99.84 114.18 27.19 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.334 0.588 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.9 m0 -99.66 158.37 15.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.279 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -111.99 120.38 41.69 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.23 33.85 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.536 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.9 m -105.92 128.37 53.74 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -81.25 -60.17 2.38 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -140.22 -65.72 0.45 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.033 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.83 -17.21 12.1 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.513 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -120.67 142.45 49.46 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 121.055 0.455 . . . . 0.0 111.262 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 49' ' ' GLY . 5.7 tt -94.35 135.75 35.42 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' HD23 ' A' ' 48' ' ' LEU . . . -150.45 170.2 30.36 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.068 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 69.5 mt -101.39 131.08 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -139.81 146.14 45.9 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.236 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.74 133.24 8.01 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.142 1.895 . . . . 0.0 111.366 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -80.44 42.58 0.6 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.781 0.801 . . . . 0.0 111.348 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -102.22 -40.56 6.72 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.22 -9.42 45.35 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 9' ' ' VAL . 35.9 m -127.01 140.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.734 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -124.6 142.08 51.62 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.628 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -84.15 99.69 10.67 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.88 153.77 48.32 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--N 1.29 -2.022 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.647 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.567 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -65.95 -54.68 23.14 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.178 0.591 . . . . 0.0 110.867 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.0 tpt -106.51 147.45 29.38 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.5 57.02 2.68 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 106.469 -2.652 . . . . 0.0 106.469 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER -57.85 135.93 56.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.653 -1.274 . . . . 0.0 108.079 -177.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 30' ' ' ASP . 51.2 mt-30 -87.69 152.46 22.13 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.983 -172.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.7 p -120.74 155.94 32.88 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.258 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 47.6 mttm -105.72 140.13 39.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.572 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 23' ' ' LEU . 99.8 t -78.79 118.79 26.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.139 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt -101.82 -34.38 9.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.809 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -124.52 154.39 40.63 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.81 154.02 28.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -113.58 -52.46 2.75 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.624 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m 58.67 88.35 0.12 Allowed Pre-proline 0 N--CA 1.431 -1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 110.487 -173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.19 153.46 39.39 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.05 2.5 . . . . 0.0 113.173 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.62 -17.68 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.73 -167.08 1.92 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -105.29 5.91 32.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.66 -31.18 16.72 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.225 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' LEU . 2.8 mp0 -74.85 178.67 5.36 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.382 0.61 . . . . 0.0 110.134 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.7 tp -94.73 136.25 35.26 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.739 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -84.49 117.06 23.44 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.976 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 9' ' ' VAL . 26.7 mt -89.96 108.42 19.71 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.696 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.22 127.62 41.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.7 p -68.54 128.14 31.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 CA-C-O 121.803 0.811 . . . . 0.0 112.253 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.67 87.59 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.882 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 3.7 t0 -87.25 169.24 12.49 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.476 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.7 t -114.27 129.36 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.322 0.649 . . . . 0.0 110.709 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.31 134.83 53.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 122.972 0.509 . . . . 0.0 110.863 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . 33.5 t70 -86.69 105.19 16.76 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 t -84.85 121.29 36.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.101 -176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -90.09 -50.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.76 152.86 18.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.158 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 10.9 pt-20 -90.1 124.43 34.8 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 168.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.49 -34.99 7.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.818 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -138.29 153.51 49.04 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -71.54 112.61 7.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.225 0.536 . . . . 0.0 109.856 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' PRO . . . 110.32 -13.02 30.95 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.423 -177.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -126.7 107.02 9.79 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.38 0.609 . . . . 0.0 110.876 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 34' ' ' GLU . 46.3 m0 -94.54 143.53 26.34 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.957 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -107.56 114.8 29.04 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.03 170.79 34.37 Favored Glycine 0 N--CA 1.42 -2.404 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -118.5 141.82 48.19 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.84 -54.92 4.54 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -132.54 -59.99 0.9 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.117 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.06 -21.6 2.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -101.91 115.64 30.98 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.955 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.97 108.54 5.94 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.83 173.2 16.56 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.954 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 18.1 tp -107.35 139.75 41.34 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -150.64 147.58 21.61 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 121.365 -0.134 . . . . 0.0 110.984 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 41.0 Cg_endo -71.3 129.45 15.99 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.089 1.859 . . . . 0.0 111.3 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 p -68.02 -22.29 64.98 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 123.7 0.8 . . . . 0.0 112.844 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -57.32 -33.06 67.32 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.964 0.506 . . . . 0.0 112.36 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -90.48 -6.66 54.57 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 57' ' ' LYS . 27.3 m -118.48 137.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.229 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 56' ' ' VAL . 13.5 mptt -116.19 131.87 56.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.802 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.21 116.13 20.94 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.995 -174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.8 pt? -78.84 126.94 31.39 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 7.1 pt-20 . . . . . 0 C--N 1.28 -2.425 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.99 -170.325 . . . . . . . . 1 1 . 1 stop_ save_